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ABSTRACT
NANOPARTICLE BUILDING BLOCKS
FOR FUNCTIONAL STRUCTURES
SEPTEMBER 2014
YOUNGDO JEONG, B.A., HANYANG UNIVERSITY
M.A., HANYANG UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Vincent M. Rotello
A major goal in material science is achieving a desired function using
structures fabricated with designed building blocks. Advanced synthetic and selfassembly techniques allow various nanomaterials to become promising building
blocks, providing the control of the interaction between building blocks. The unique
properties of nanomaterials can be transferred to structured systems. Among
nanomaterials, inorganic nanoparticles such as gold nanoparticles (AuNPs),
magnetic particles, and quantum dots (QDs) provide useful physical properties
stemming from their inorganic core, large surface areas, and oriented surface
functionalities. My research has focused on fabricating functional systems using
gold nanoparticles (AuNPs), manipulating the interaction between AuNPs, bioentities, and small molecules. To construct complicated three-dimensional structures
and embed functions, emulsion templates for the fabrication of the capsule structures
and various supramolecular chemistry between AuNPs or AuNP and enzyme were
employed. My research consisted of 2 approaches: first, through both the design of
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the monolayer at the molecular level and the emulsion template, (1) enzymeimmobilized microparticles having high immobilization efficiency and reusability
were fabricated; (2) correlations between the mechanical properties of the AuNP
monolayer film and the binding affinities between nanoparticle components were
investigated; and (3) stable 100 nm sized nanoparticle-dendrimer hybrid capsules as
a drug delivery carrier were fabricated and evaluated in vivo. Second, by
encapsulating various hydrophobic catalysts in the hydrophobic pockets of the
monolayer of water-soluble AuNPs, (4) water-soluble nanoreactors were developed.
By incorporating host-guest elements on the surface of water-soluble nanoreactors,
(5) artificial enzymes capable of catalyzing bio-orthogonal chemical reactions inside
living cells which can be regulated by the addition of host or guest molecules were
fabricated. As can be seen, engineering of the AuNP surface at the molecular level
opens new avenues for the fabrication of numerous functional materials.
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CHAPTER 1

NANOPARTICLES AS BUILDING BLOCKS
1.1 Introduction
Nanoparticles provide useful building blocks for the fabrication of functional
structures, implanting their unique properties in self-assembled structures.1 Monolayerprotected inorganic nanoparticles have particularly been employed in material science via
control of their surface functionalities.2 Nanoparticles represent hybrid systems of nanoscale metal cores covered by self-assembled monolayers of organic ligands. The use of
nanoparticles as building blocks takes advantage of both the dimensions and the physical
properties of the inorganic core, as well as the functions of the organic surface periphery.
Nanoparticles exhibit a number of unique physical and chemical properties
relative to bulk material. The distinctive properties of nanoparticles include their
enormous surface area, oriented functionalities, and structures having a rigid core and
soft monolayer. Additionally, the tunable properties of nanoparticles –their components,
size, shape, and functionalized surface have made them attractive building blocks in
various material fabrications, including electronic and optical devices, chemical and
biological sensor platforms, cell labeling and imaging, and cancer therapy.3
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Figure 1.1 Schematic illustrations of monolayer-protected gold nanoparticles: an
inorganic gold core protected by an organic monolayer that can control a myriad of
interactions between many other building blocks.

Functionalization of gold nanoparticles (AuNPs) is achieved by a Murray placeexchange reaction 4 with appropriate functional ligands. Incorporation of multiple
functionality within the scaffold of a single particles coupled with a scale comparable with
biomacromolecules (e.g. proteins and DNA), other particles, and small molecules provides
multiple applications for functional self-assembled structures. For example, intricately
designed structures have been fabricated using DNA origami strategies and DNA
functionalized AuNPs.5 Furthermore, colloidal micro/nano capsule structures have also
been developed through using surface functionalized AuNPs and oil/water interfaces for
delivery vehicles,6 high-throughput template for analysis 7 and fabrication of inorganic
protocells.8 This thesis work utilized AuNP as a building block for the fabrication of
various functional structures. As background to this work, self-assembly of functionalized
AuNPs, fabrication of stable colloidal microcapsules, and supramolecular interaction
between small molecules and the monolayers of AuNPs will be discussed in this chapter.
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1.2 Self-assembled structures using nanoparticles
To embed various functions such as catalytic ability or mechanical strength into
AuNP-involved self-assembled structures, one must understand the interaction of AuNPs
with various materials such as proteins, polymers, and small molecules possessing
desirable functions. That the functionalities of AuNPs can be easily modified through a
large number of ligands and the functionalities have orientation is key to dictate the
processes in self-assembly. Therefore, proper design of the interaction between those
materials and AuNPs allows construction of intended self-assembled structures with
desirable functions.
Various supramolecular interactions including electrostatic attractions,9 hydrogen
bonding, 10 pi-pi stacking and van der Waals interactions 11 between nanoparticle and
proteins have been designed to control nanoparticle self-assemblies. Rotello et al. have
developed a ‘chemical nose’ sensing system using functionalized nanoparticles and their
various interactions. 12 Specific signal patterns of this system can be obtained for
identifying proteins, controlling the affinities between the various functionalized AuNPs
and proteins. Using the self-assembly of negative charged AuNPs and α-Chymotrypsin,
the catalytic activities of α-Chymotrypsin were modulated.13 In this study, the chargecharge interaction between AuNPs and substrates can control the diffusion rate of the
substrate allowing it to enter the active site of the enzyme.
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Figure 1.2 Schematic illustration of a “chemical nose” sensor array based on AuNPfluorescent polymer/GFP conjugates. (a) Competitive binding between protein and
quenched polymer-AuNP complexes leads to the restoration of fluorescence (b)
Combination of an array of sensors generates fingerprint response patterns for individual
proteins. (c) Competitive binding between protein and nanoparticle−GFP complexes
leads to fluorescence light-up. (Adapted from ref.12d )
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Figure 1.3 (a) Molecular structure of α-chymotrypsin. (b) Chemical structure of aminoacid-functionalized gold nanoparticles and SPNA-derived substrates. (c) Schematic
representation of monolayer-controlled diffusion of the substrate into, and the product
away from the active pocket of nanoparticle bound α-chymotrypsin. (Adapted from ref.13)
Various covalent bonds between AuNPs have been developed for the fabrication
of stable nanoparticle composite films in various areas. Chemoselective nanoporous
membranes,14 drug-release controlling films,15 and chemical responsive films16 have been
fabricated using a direct covalent assembly of AuNPs and polymers. Using covalent
chemistries between cores and polymers or the functional group of AuNPs and polymers,
desirable properties and structures of films such as mechanical strength and porosity can
be achieved.
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1.3 Fabrication of stable nanoparticle-based colloidal microcapsules
In recent years, there has been increasing interest in the fabrication of
microcapsules (MCs) due to their widespread applications as delivery vehicles,
microreactors, catalyst supports and encapsulants.17 Their small size, large surface area,
large inner volume, high stability and oftentimes stimuli-responsiveness make them an
ideal platform for drug encapsulation and delivery. Until recently, utilization of
nanoparticles (NPs) as the principal building blocks of MCs has been limited due to
challenges in obtaining stable MCs.
The focus of this chapter is highlighting recent advances in the fabrication of
stable colloidal MCs where NPs are used as building blocks. In general, these MCs are
fabricated using emulsion-templating in which a liquid-liquid microemulsion is utilized
to self-assemble colloidal micro/nanoparticles at the interfaces. While there are numerous
reports of fabrication of large MCs using colloidal particles that are in the micron to
submicron size range, it is only in recent years that fabrication of MCs with NP building
blocks have been realized. Incorporation of colloidal NPs as building blocks expands the
functional capabilities of MCs by contributing of various attributes inherent to the NPs
due to their nanoscale dimensions. For example, the utilization of plasmon-active NPs
such as gold and magnetically active NPs such as iron-oxide can enable fabrication of
MCs responsive to external triggers such as laser and magnetic fields, respectively.18
Proper selection of ligands on NP surfaces, inter-particle linkages or crosslinking
strategies would allow tuning the properties of colloidal MCs including permeability,
mechanical stability, biocompatibility, electric properties, and stimuli responsiveness.
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While emulsion-templating can be employed to obtain MCs composed of NPs, it
is important to stabilize these MCs, thereby providing stability that can overcome thermal
disorder to these colloidal assemblies allowing products for practical applications.
Control over the assembly process at both the micro- and nanoscopic level would allow
fabrication of stable MCs.19 NPs with an appropriate ligand shell can be employed to
provide stability of the self-assembled MCs via either covalent or non-covalent
interactions. In the next sections, a short introduction to the factors affecting the stability
of the emulsion based colloidal MCs is followed by examples from recent literature
providing a glimpse of the various approaches that have been utilized to fabricate stable
MCs by stabilizing the interparticle interaction at the liquid-liquid interface.

1.3.1 Factors affecting stability of the colloidal capsules
“Pickering emulsions” or emulsions stabilized via colloidal particles were
discovered by S. U. Pickering almost a century ago. It is well-established that
amphiphilic colloidal particles show a propensity to stay at the interfaces to minimize the
interfacial energy between immiscible liquids.20 Change in interfacial energy is related
not only to the effective radius (r) of the particle but also to the surface tension between
the particle and oil(O) and water (W) by the Pieranski equation as given below.21

ΔE = −

2
π r2 #
$γ o/w − (γ p/w − γ p/o )%&
γ o/w

Where γp/o = interfacial energy of particle-oil, γp/w= interfacial energy of particle-water
and γo/w = interfacial energy of oil-water.
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The strong particle-size dependence on the energy change in the liquid-liquid
interface makes it clear that the low energy gain due to small particle size makes the selfassembly of NPs much more demanding than for larger particles. Thermal fluctuations at
room temperatures are sufficient to displace the NPs from the interface. As evident from
the above equation, another factor governing stability of the assembly of NPs is their
wettability. It is well established that only particles with intermediate wettabilty produce
kinetically stable emulsions.22

1.3.2 Fabrication of stable capsules from self-assembled nanoparticles at the oilwater interface
Interparticle interactions at the liquid-liquid interface are governed by various
interfacial forces such as capillary forces, solvation forces, electrostatic force, van der
Waals forces, and fluctuation forces. 23 Chemical interactions between the adsorbed
particles on the interface can be employed as a useful tool to stabilize the colloidal shell
of MCs. Stronger lateral interparticle interactions will facilitate formation of selfassembly of NPs at the interface by minimizing the chance for NPs to escape from the
interface due to thermal fluctuations.
By crosslinking the NPs assembled at the oil-water interface, significant advances
have been achieved in the fabrication of stable colloidal MC. Crosslinking the NPs leads
to the formation of a stable shell at the emulsion interface. This confers the necessary
mechanical stability to the MCs enabling their isolation and transfer after fabrication. The
most widely used approach utilizes crosslinking NPs at the oil-water interface via
chemical bond formations between inter-particle surface ligands. Thus, design and
8

	
  

synthesis of novel ligands that afford surface reactive NPs are very important for this
purpose. In general, crosslinking between NPs at the liquid-liquid interface to yield stable
microcapsules can be achieved by designing systems that benefit from either covalent
interaction between NPs and/or non-covalent interactions between NPs.
Judicious choice of organic ligands on the NP surface provides tools for
employing different types of covalent crosslinking to obtain NP assemblies with
improved mechanical properties and structural stability to facilitate handling and transfer.
Lin et al fabricated stable MCs by crosslinking appropriately modified NPs at room
temperature using ring opening metathesis polymerization (ROMP).24 CdSe-ZnS quntum
dots (QDs) coated with a norbornene based ligand were assembled at the oil-water
interface and those were subsequently crosslinked through a modified 2nd generation
Grubb’s catalyst in the inner phase of the water-in-oil emulsion (Figure 1.4). Removal of
the interface by adding methanol to the MCs solution did not disrupt the NPs assembly,
thus demonstrating the stability of the arrested crosslinked assembly. In a simpler
approach, Russell and Emrick fabricated MCs using gold NPs coated with a hydroxylterminated amphiphilic ligand. Interfacial crosslinking of the NPs assembled at the
interface using terephthaloyl chloride led to stable MCs.25
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Figure 1.4 (a) Norbornene functionalized CdSe QDs and water-soluble Grubb’s catalyst
(b) Confocal image of the microcapsules stabilized by crosslinking of ROMP. (Adapted
from ref. 31)
Molecular recognition-based, directed self-assembly of NPs provides a powerful
tool to fabricate novel functional materials. 26 The multivalent nature of interactions
between the NP building blocks at the interface provides an opportunity to utilize weaker
non-covalent interactions to obtain stable microcapsules. Furthermore, the reversible
nature of noncovalent interactions shows potential for the fabrication of dynamic systems.
Examples from recent literature as outlined below highlight that molecular recognition
between complementary molecules can be utilized to design NP systems capable of
benefitting from such stabilizing interactions at the liquid-liquid interface.
In a recent work, Möhwald et al. utilized hydrogen bonding at the oil-water
interface to demonstrate stepwise assembly of three different types of NPs having
different cores and ligands at the liquid-liquid interface to fabricate asymmetric thin
films.27 Ligands based upon DNA bases such as thymine, adenine and adenosine 3’monophosphate were used for the assembly process. As a first step, gold NPs were
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modified by thymine-functionalized ligands at the toluene-water interface. Second,
thymine ligand-coated gold NPs were linked with adenine thiol from the oil phase and
adenosine 3’-monophosphate from the water phases via complementary base pairing
(Figure 1.5). This surface functionalization strategy using bi-phase allows attachment of
organo-soluble Ag and water-soluble CdTe NPs onto the gold NPs from their respective
bulk phases. Thus, asymmetric trilayer thin films of three different NPs were fabricated
using phase-selective surface-modification of NP surfaces at the oil-water interface.

Figure 1.5 DNA base pairing of NPs that self-assembled at the oil-water interface.
[Adapted from ref. 33]

11

	
  

Fabrication of stable colloidal microcapsules using NPs has been achieved in
recent years. As demonstrated in the above mentioned examples, fabrication of
practically useful and functional microcapsules could only be achieved by the
stabilization of the NP array formed at the liquid-liquid interface, by establishing either
non-covalent or covalent linkages between the building blocks. Ability to tune the
interactions between the NPs will also open routes to fabricate stable yet responsive MCs
that would allow controlled and selective transport of materials in and out of the capsule.
Such aspects can be tailored into the ligand shell of the NP components using a wide
variety of available organic reactions, thus enabling design and fabrication of novel NP
based microcapsules.
1.4 Non-covalent incorporation of hydrophobic molecules into AuNP monolayers
Non-covalent incorporation of hydrophobic molecules such as transition metal
mediated catalysts, cancer drugs, or anti-biotics into AuNP monolayers provides an
alternative strategy combining the properties of AuNPs and the hydrophobic molecules.
Hydrophobic molecule encapsulation with AuNPs relies on the use of ligands that
produce a hydrophobic interior to the monolayer. Structurally, the radial nature of the
monolayer results in a decrease in ligand density as one goes farther from the core of
small AuNP cores (< ~6 nm).28 Consequently “hydrophobic pockets” are created inside
the monolayer of the AuNP into which hydrophobic materials can be partitioned.
Pasquato et al. demonstrated the encapsulation of radical probes in AuNP monolayers,
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using EPR spectroscopy to monitor the partition of the lipophilic probe between a
monolayer of AuNP and bulk water.29 As expected, smaller particles featuring more
strongly radial monolayers favor guest encapsulation (Figure 1.6).

Figure 1.6 (a) Schematic representation of AuNP and nitroxide probe inclusion. (b) Plot
of the ratio between the concentration of 2 partitioned in the monolayer and that of the
free species (! 16 nm;  3.4 nm; " 5.3 nm) as a function of [HS-C8-TEG, 1] bound to
the gold.
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The concept of monolayer encapsulation has recently been applied to drug
delivery. Rotello et al. have developed a biocompatible AuNP carrier that employs
hydrophobic pockets to first encapsulate drugs and then deliver them into cancer cells.30
The particles (~ 2.5 nm core) featured a hydrophobic alkanethiol interior and a
hydrophilic shell composed of a tetra(ethylene glycol) (TEG) unit terminated with a
zwitterionic

headgroup

designed

to

minimize

nonspecific

binding

with

biomacromolecules 31 and other cell surface functionality (Figure 1.7). Hydrophobic
payloads were kinetically entrapped in the monolayer, with the resulting host-guest
materials stable in buffer and serum. The entrapped payloads were released into cells by
membrane-mediated diffusion, as demonstrated both by fluorescence microscopy (using a
fluorophore payload) and through drug efficacy with therapeutic guests. No particle
uptake was observed with these systems using ICP-MS, making these systems excellent
candidates for passive targeting using the enhanced permeability and retention (EPR)
effect.32
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Figure 1.7 (a) Structure of particles and guest compounds: Bodipy, TAF, and LAP, the
number of encapsulated guests per particle (b) Cytotoxicity of AuNPZwit complexes
measured by Alamar blue assay after 24 h incubation with MCF-7 cells. IC50 of AuNP
(NP), equivalent drugs (Drug), and free drugs are shown in the table.

1.5 Dissertation overview
Fabrication of functional structures with intended structures relies on engineering
the interfaces between nanoparticle building blocks or other building blocks and
nanoparticles. My research has been oriented toward the fabrication of functional
structures using various interfaces between nanoparticles and other functional materials
such as enzymes, catalysts, and polymers. To achieve this, I have employed a synergistic
approach, combining materials, surface science, organic synthesis, and biology to
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develop surface-functionalized AuNPs with a tailored monolayer. In the following
chapters, details of designing functionalized AuNPs and their use as a building block are
described.

Figure 1.8 Dissertation overview. Schematic illustration of the fabrication of the
functional structures using AuNPs building blocks described in this thesis.

In Chapter 2, a capsule scaffold for enzyme immobilization will be discussed.
Emulsions stabilized by enzyme-nanoparticle (NP) complexes were used to fabricate
robust biocatalytic scaffolds after core solidification. These biocatalysts couple ease of
formation, high retention of enzymatic activity and reusability.
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Chapter 3 will discuss the fabrication of nanoparticle monolayer films that have
tunable elastic modulus. In this chapter, the elastic modulus of an ultrathin NP monolayer
film is tuned by modulating the binding strength between the NPs at the molecular level.
NP monolayer films constructed by crosslinking NPs of different binding affinities were
fabricated at oil/water interfaces. By inducing buckling patterns on these films, the
correlation between the binding affinity of NPs and the elastic modulus is investigated.
In chapter 4, the fabrication of nanoparticle dendrimer hybrid capsules for drug
delivery will be discussed. By transferring a two-dimensional nanoparticle-dendrimer
composite film to a three-dimensional capsule structure, the resulting materials provide
controlled drug release, stability, and therapeutic efficacy in vivo. The NDHCs act as a
drug carrier for cancer therapy in vivo, displaying efficient therapeutic and passive
targeting ability.
Chapter 5 will describe the solubilizaton of hydrophobic catalysts through water
soluble nanoparticle hosts. We report the solubilization of various hydrophobic transition
metal catalysts achieved by using hydrophobic pockets of water soluble gold
nanoparticles. Besides preserving original catalyst activity, this nanoparticle platform
provides a protective environment for the hydrophobic catalyst. Grubbs, Cp*Ru(cod)Cl,
and Wilkinson catalysts encapsulated in the water soluble AuNPs are used for ringopening metathesis polymerization, allyl carbamate cleavage and hydrogenation of
alkenes, respectively. Recyclability of a nanoparticle-catalyst system is examined for the
Wilkinson catalyst. This work demonstrates a versatile platform for the encapsulation of
different hydrophobic catalysts, allowing a wide range of catalysis in water.
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In Chapter 6, fabrication of allosterically-controlled bioorthogonal catalysis will be
discussed. Artificial nanozymes that catalyze bioorthogonal reactions broaden the
functional possibilities of intracellular chemistry. Effectively delivering and regulating
the activity of protein-sized, catalytic systems is challenging due to both the complex
intracellular environment and catalyst instability. We report the fabrication of nanometersized bioorthogonal nanozymes through the encapsulation of hydrophobic transition
metal catalysts into a monolayer of water-soluble gold nanoparticles. The activity of
these catalysts could be reversibly controlled by binding a supramolecular cucurbit[7]uril
‘gate-keeper’ onto the monolayer surface, providing a biomimetic allosteric control
mechanism. The efficacy of this gated nanozyme was demonstrated by the triggered
cleavage of an allylcarbamate inside living cells, providing a new type of artificial
allosteric enzyme for use in imaging and therapeutic applications.
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CHAPTER 2

REUSABLE BIOCATALYTIC MICROPARTICLES SELF-ASSEMBLED FROM
ENZYME-NANOPARTICLE COMPLEXES

2.1 Introduction
Immobilized enzymes provide highly regio- and stereospecific catalysts for
synthesis,1 pharmaceuticals,2 biosensors,3 and biofuel cells.4 A major goal in designing
enzyme immobilization strategies is fabricating scaffold structures that overcome
limitations of free enzymes, such as removal and re-use of the enzyme and lack of longterm solution5 and interfacial stability.6
A number of scaffolds have been developed to immobilize and stabilize enzymes,
including gels,7 macromolecules,8 nanoreactors,9 carbon nanotubes,10 and other surfaceanchored systems.11 Microparticles (MPs) provide particularly attractive scaffolds for
enzyme immobilization due to their large surface area and ease of separation from the
reaction mixture by centrifugation, filtration or magnetic methods.12
Enzymes can be covalently bound to modified particles via various chemistries13
or adsorbed via hydrophobic, Van der Waals, and electrostatic forces. 14 However,
biocatalysts generated by these approaches can face challenges including low
immobilization yield,13 leaching of enzymes from the scaffolds,14 and loss of enzyme
activity.13,15
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In recent studies, we successfully immobilized enzyme-NP complexes at oil/water
interfaces through electrostatic self-assembly.6, 16 While the resulting microcapsules
effectively retained the activity of the enzyme, re-use of the capsules was prevented by
the liquid nature of their core. Herein, we report a versatile technique for fabrication of
crosslinked microparticle scaffolds (CLMP) for enzyme immobilization through
polymerization of the hydrophobic core of enzyme-NP microcapsules (Figure 2.1). These
solidified scaffolds retain high enzymatic activity while providing separability using
magnetic NPs immobilized into the core. This work has been reported as a
communication in the Chemical Communications.17

Figure 2.1 Schematic illustrations for the formation of catalytic CLMPs, core
polymerization using 1st generation Grubbs’ catalyst, and chemical structure of the
cationic gold nanoparticles used in this study.
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2.2 Results and discussion
2.2.1 Formation of enzyme-nanoparticle complexes
The catalytic CLMPs presented here consist of enzymes, NPs and polymerized
cores. For our studies we used Candida rugosa lipase, an industrially important
enzyme. 18

This lipase was selected because its high chemoselectivity, relative

insensitivity towards non-aqueous solvents, and stability over broad pH and temperature
ranges.19 In our CLMPs positively charged gold NPs (AuNPs) functionalized with
trimethylammonium tetra (ethylene glycol) ligands were used to bind to the anionic
lipase through electrostatic interactions with minimal denaturation.20 The solid core was
prepared by mixing dicyclopentadiene (DCPD) monomers, 1st generation Grubbs’
catalyst, and 1,2,4-trichlorobenzene (TCB) to adjust the buoyancy and control the rate of
polymerization.
To effectively stabilize the microcapsules, the charge density of enzyme-NP
complexes was optimized by the molar ratio of NP to enzyme. Since the high surface
energy associated with the emulsions requires materials with a low charge density for
stabilization,21 zeta potential values of enzyme-NP complexes in terms of the molar ratio
were measured to fabricate the complexes with the lowest charge (Figure 2.2a). The
complexes made using a 2:1 NP to enzyme ratio resulted in essentially neutral particles
with a -0.213 mV zeta potential value. This 2:1 NP to enzyme ratio was used for all
subsequent experiments.
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Figure 2.2 (a) Zeta potential values of enzyme-NP complexes fabricated at varied molar
ratios of NP to lipase, (b) Optical image of CLMPs.

After formation of the MCs by homogenization and polymerization of the core
upon standing (2 h), the CLMP biocatalysts were found be spherical with diameters of 20
± 7 µm (Figure 2.2b). IR spectroscopy was used to confirm the polymerization of the
core scaffold, indicated by the increased absorption intensities at 1665 cm-1 and 965 cm-1
characteristic of the ring-opened product of poly(DCPD) (Figure 2.3).22
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Figure 2.3 IR spectrum of the CLMPs, DCPD and lipase

2.2.2 Fabrication of crosslinked microparticle scaffolds
The efficiency of a biocatalyst is determined by accessiblity of substrates, enzyme
immobilization yield, retained activity and reusability. FITC-labeled lipase was used for
the fabrication of CLMPs to demonstrate the successful immobilization of lipases on the
CLMP surface. A distinct green fluorescence was observed on the entire surface of
CLMPs under 494-nm excitation, proving the presence of lipases (Figure 2.4a). To
further study the structure of CLMPs, FITC-labeled lipases and an oil phase containing
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1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine perchlorate (DiI) were used for
investigation with confocal microscopy. As shown Figure 2.4b, FITC-labeled lipases
were selectively located on the surface and the red fluorescence of the DiI was observed
in the core. These results indicated selective enzyme-immobilization at the surface of
CLMPs, providing accessibility for reactants.

Figure 2.4 (a) A fluorescence microscope image of catalytic CLMPs fabricated using
AuNPs and fluorescein-labeled lipase in a buffer solution (b) a confocal image of a FITClabeled lipase immobilized CLMP including DiI in the core (488 nm and 543 nm
excitation) c) Formation of catalytic CLMPs incorporating Nile red and magnetic NPs in
the core.

31

	
  

2.2.3 Crosslinked microparticle scaffolds as a biocatalyst
The quantity of lipase immobilized onto the CLMPs was calculated by measuring
the amount of residual free enzymes in the water phase using a Bradford protein assay.
Less than 5% of the enzymes remained in the water phase of CLMPs, indicating that >95%
of the enzyme was successfully immobilized on the polymerized scaffolds (Figure 2.5a).
The enzymatic activity of the CLMPs was determined through fluorometric
enzyme activity assays using 8-octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt
(OPTS) substrates in an aqueous solution. 23 Significantly, the activity of catalytic
CLMPs was almost 3-fold higher than that of free lipase, with no detectable auto
hydrolysis observed (Fig. 3b). This enhancement in activity presumably arises from the
hydrophobic environment of the scaffold, as prior studies have observed increases in
activity in hydrophobic environments. 24 In addition, the calculated ionic strength of 0.2
M OPTS solutions is 1.2 M, indicating that the CLMPs retain enzymatic activity in high
ionic strength environments.
A useful feature of the structure of CLMPs is that the system can be readily
equipped with magnetic properties through the simple addition of magnetic NPs into the
oil phase. To demonstrate this versatile feature, Nile red and oleic acid-functionalized
magnetic nanoparticles (10 nm core diameter Fe2O3 NPs25) were added into the oil
mixture. After the fabrication of the CLMPs using this oil phase, the MPs can be
efficiently collected using a magnet (Figure 2.4c).
Reusability of the enzymes on the CLMPs was investigated through repeated
enzymatic activity assays. The CLMPs and enzyme-immobilized microcapsules were
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placed in a 0.2 µm pore membrane bags for easy separation from the reaction mixture and
to prevent loss during the washing process.26 As shown in Figure 2.5b, the CLMPs
exhibited essentially identical activity after repeated uses, while enzyme-immobilized
microcapsules with liquid cores lost 80% of their initial activity after 2 cycles of use. In
addition to reusability, the CLMPs provided exceptional long-term stability. In aqueous
solution, the CLMPs retained complete enzymatic activity over 10 days while the free
lipase lost almost of all of their activity at room temperature in 3 days (Figure 2.5d).
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Figure 2.5 (a) The percentage of free lipase remaining in the water phase after the
CLMPs construction (b) activity assays of lipases of the CLMPs and free lipase in
phosphate buffer (5 mM) and inset shows the relative activity (free enzyme solution =
100%) (c) the relative activity of the catalytic CLMPs before and after core-solidification
with recycled use (d) relative activity of the CLMPs and free lipase in terms of time

2.2.4 Crosslinked microparticle scaffolds in organic solvent
To ascertain the utility of the catalytic scaffold for use in organic solvents, the
core stability of the CLMPs was investigated. When acetone was added to the solutions
of enzyme-immobilized microcapsules, the CLMPs kept their original shape while the
microcapsules with unpolymerized core were observed to increase in size and undergo
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deformation in shape (Figure 2.6 a,b). An enzyme activity assay was performed in a
mixture of acetone and water (1:1). The CLMPs were shown to retain enzymatic activity
(Figure 2.6c).

Figure 2.6 Optical images of (a) enzyme-immobilized CLMPs (b) CLMPs in acetone (c)
activity assay of enzyme-immobilized CLMPs and free enzyme in a mixture of acetone
and water (1:1)

2.3 Summary and future outlook
In summary, we have developed a new strategy for the creation of supported
biocatalysts through core polymerization of nanoparticle-stabilized microcapsules. The
resulting materials provide stabilization of the enzyme, ease of removal of the catalyst,
and increased tolerance of non-aqueous solvents. The versatility of these microparticles
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can be further enhanced through incorporation of materials into their core, providing an
effective scaffold for biocatalysis.
In this study, we found out the immobilized enzymes can preserve their activity in
harsh condition such as organic solvent or high ionic strength. Based on this result, we
can assume that the immobilized enzyme can preserve their original structures at the
harsh condition since the polymer matrix presumably holds their structures. Therefore,
the immobilized enzymes can be used at high temperature with high activity, overcoming
the limitation of enzymes.

2.4 Synthesis of materials and experimental methods
Lipase (candida rugosa lipase), dicyclopentadiene (DCPD), ruthenium-based 1st
generation Grubbs’ catalyst and 1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine
perchlorate were purchased from Sigma-Aldrich. Trichlorobenzene (TCB) was purchased
from Fluka Chemicals. Compat-Able Protein Assay Kits and Coomassie blue (Bradford
protein assay kit) were purchased from Thermo Fisher Scientific Inc. 8Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt (OPTS) was purchased from
Markergene Technology Inc.
Zeta potential values were measured using a MALVERN Zetasizer Nano ZS
instrument. Each sample was scanned three times and an average value was reported.
Optical and fluorescence microscopy images were taken using an Olympus IX51
instrument and enzymatic activity assays were performed by plate fluorescence reader
(SpectraMax M5). Confocal pictures were obtained on a Zeiss LSM 510 Meta
microscope using 63X objective.
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2.4.1 Synthesis of ligand and fabrication of nanoparticle
Positively charged gold nanoparticles (AuNPs) were synthesized according to
previous reports.27 In brief, pentanethiol-coated AuNPs with a core diameter of 2 nm
were synthesized using the Brust-Schiffrin two-phase method. 28 A Murray placeexchange reaction was used to obtain the quaternary ammonium functionalized AuNPs.29
Oleic acid coated iron oxide nanoparticles with a core diameter of 10 nm were
synthesized through the thermal decomposition of Fe(CO)5 in organic solvents and
subsequent oxidation in air.25

2.4.2 Experimental methods
2.4.2.1 Enzyme-immobilized microparticle (CLMP) preparation
0.72 µM of AuNPs functionalized with trimethylammonium tetraethylene glycol
ligands were mixed with 0.36 µM of lipase in 200 µL of 5 mM phosphate buffer (pH 7.4).
The oil phase was prepared through mixing 90 µL DCPD, 8 µL TCB and 2 µL of 5%
Grubbs’ catalyst in toluene. Immediately after preparing the oil phase, 5 µL of the oil
phase was added to the mixture of lipase and AuNPs. After adding the oil phase, the
solution was mechanically agitated via amalgamator. After 2 h, enzyme-immobilzed MPs
were purified using a membrane bag.
2.4.2.2 Enzyme immobilization yield (enzyme quantification method):
The immobilization yield of the lipases was calculated by measuring the amount
of residual enzymes in the solution of MPs using a Bradford protein assay. Free
nanoparticles and any interfering substances were first removed using Compat-Able
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Protein Assay Kit and the calibration with a standard sample was carried out.
2.4.2.3 Enzyme activity assay
Enzyme activity assays in a 5 mM buffer solution were performed using OPTS as
a substrate and fluorescence of products were analyzed over time using plate fluorescence
reader (λex/λem: 460/510 nm). The molarity of the OPTS was 0.2 M and calculated ionic
strength was 1.2 M, which is 6-fold higher than that of 100 mM phosphate buffer. 4nitrophenyl acetate was used as the substrate for enzyme activity assays in the mixture of
acetone and water and the absorbance of products was observed at 450 nm. Washing
processes were performed before the repeated reuse of biocatalysts as shown in Figure
2.7 The MPs and enzyme-immobilized MCs in 100 µL water phase were washed by 4 L
of water for 4 hour using 0.2 µm pore-sized membrane bag.

Figure 2.7 (a) Schematic illustration of the repeated washing processes and enzyme
activity assays of MPs for recycling test (b) picture of 0.2 µm pore size membrane bag
including the MPs
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CHAPTER 3

TUNABLE ELASTIC MODULUS OF NANOPARTICLE MONOLAYER FILMS
BY HOST-GUEST CHEMISTRY
3.1 Introduction
Thin films containing inorganic nanoparticles (NP) have attracted widespread
attention due to their applications in functional devices that benefit from the characteristic
optical,1 magnetic,2 or electronic,3 properties of the incorporated NP.4 Furthermore, the
solid core of inorganic NPs provides a platform for the engineering of mechanical
properties.5 The pliability of soft materials has been integrated through the creation of NP
composite materials with support materials such as polymers, 3b,4b proteins,6 and other
materials. 2,7 In these NP composite materials, the mechanical properties can be tuned by
controlling the NP composition. However, the fabrication of ultrathin NP composite
materials with homogeneous mechanical properties is a challenge since the unintended
aggregation of NPs in the soft materials generates defect sites that have less NP
composition.8
Recently, there have been a few reports on the manufacture of robust freestanding ultrathin films and membranes without defect sites from NPs alone.9 These
fabrication processes generally rely on supramolecular self-assembly of NPs through
designed interactions between the outer ligand shells of individual NPs. For example,
Schmid et al. reported a method that fabricate ordered two-dimensional NP monolayer
film on polymer film. 9c In spite of the ultrathin nature of the NP films, the multiple non-
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covalent interactions between the NPs can provide useful mechanical properties. To
investigate the mechanical properties at the thickness limit of the NP films, monolayer
and multilayer films of NPs have been studied. Mueggenburg et al. determined that the
elastic modulus of a gold NP array was related to the structural arrangement of the NPs
within the film.10 Lee et al. investigated the viscoplastic behavior of CdSe NP films
hundreds of particles thick.11 To date, the design of ultrathin NP films allowing their
mechanical properties to be adjusted in a controlled fashion has not yet been investigated.

3.1.1 Controlling the mechanical properties of nanoparticle composite films
Modulation of the supramolecular interactions between NPs in the NP films can
allow tuning of the bulk mechanical properties. Supramolecular assemblies including
those based on electrostatic interactions, hydrogen-bonding, and hydrophobic forces have
been harnessed to dictate the properties of self-assembled structures by means of
modulated non-covalent interactions.12 Particularly useful are the engineered interactions
provided by the designed building blocks developed in the field of host-guest chemistry.
Our hypothesis was that the tunability of host-guest processes could be used to
dictate the mechanical properties of ultrathin particle sheets. Multivalent interactions
between NP would modulate the strength of the inter-NP interactions, in turn defining the
mechanical properties of the macroscopic self-assembled NP film. Here, we present the
fabrication NP monolayer films at the oil/water interface that are laterally crosslinked
using specific host-guest chemistry, thereby tailoring the binding affinities between NPs
Different divalent molecular linkers were designed to complex with cyclodextrindecorated NPs to form NP films with varying interparticle interaction strengths. Buckling

44

	
  

wavelength was then used to demonstrate control of the thin film modulus, with the
affinity of the host-guest interactions directly correlated to binding affinity of the
recognition elements. (Figure 3.1). This work has been reported as a communication in
the Advanced Materials.13

Figure 3.1 Structure of (a) 2-nm β-CD NPs and (b) cross-linker molecules with various
binding affinities to the β-CD-NPs. (c) Scheme for the film formation at the oil/water
interface. (d) After formation of the NP film, the internal liquid phase (dicyclopentadiene
(DCPD) and Grubbs’ catalyst) was polymerized, which reduced the internal volume and
generated buckling patterns of the NP films crosslinked by the designed linkers on the
surface of the particle.
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3.1.2 Buckling-based metrology for measuring elastic modulus
Given the fragility of monolayer NP films we used buckling as a probe for
mechanical properties. Buckling-based metrology is an effective method for the
determination of elastic moduli of thin films.14 In brief, the thin film of interest is
transferred to a relatively thick flat template and subjected to an applied compressional
strain that leads to buckling instability. Depending on the properties of the thin film and
substrate, unique buckling patterns are generated that minimize the overall energy in the
system. By assuming a sinusoidal waveform of the generated buckling instability, the
wavelength of buckling (d) can be expressed by Equation 114:
1/3

3
!E $
! d $
f
&& or E f = 3Es #
d = 2π h ##
&
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where h is the film thickness, Ē = E/(1-ν2), E is the elastic modulus, ν is the Poisson’s
ratio, and the subscripts f and s represent film and substrate, respectively. The modulus
mismatch is estimated by buckling wavelength and the thickness of the film. 14,15 This
method has been used previously to describe NP film formed at the air/water flat
interface. However, since the measurement of the binding affinity between the NPs and
linkers at the flat interface is challenging due to the small interfacial area, the NP
monolayer films discussed here are formed at a spherical interface of oil/water emulsion
to increase surface area. To estimate the modulus mismatch of the NP film, Cao’s
spherical model16 that defines the relationship between the buckling wavelength and the
radius of the sphere substrate was adapted. The relationship can be expressed as in
Equation 2:
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where a and b are fitting parameters and R is the radius of the sphere. Cao et al.
demonstrated the effect of the curvature of the film (R/h) on the normalized buckling
wavelength (d/R) of the thin films through numerical simulations and experimental
observation. 16a According to Cao’s work and other subsequent studies, 16 the values of a
and b are associated with the elastic modulus mismatch between the film and the
substrate, and the geometry, respectively. 16a We constructed NP films by cross-linking
NPs of different binding affinities on spherical substrates of various diameters. From
their buckling patterns and curvatures, the coefficients a of each of the NP films were
gained. By tracing the coefficient a of the films and the binding affinity between the NPs,
we find the binding affinity effectively influences the elastic modulus of the NP films.

3.2 Results and discussion
3.2.1 Nanoparticle monolayer film on the spherical emulsions
To fabricate the films on spherical substrates, NP films were formed at the
oil/water interface of emulsions. When the oil droplets containing the linker molecules
were added to an aqueous NP solution, the NPs self-assembled at the oil/water interface
to minimize the surface energy. The linkers present in the oil phase cross-linked the β-CD
NPs, causing a NP membrane shell to form (Figure 3.1c). By shrinking and solidifying
the inner phase of the emulsion via polymerization, we were able to obtain buckling
patterns of the NP films on a spherical substrate,17 (Figure 3.1d) and thus deduce the
elastic modulus of the NP films based on Equation (2). To confirm the formation of the
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NP film at the oil/water interface of the spherical emulsions, a Pickering emulsion18 was
produced using oil (chloroform) containing the linker (AB-Hex-AB) and β-CD NPs as
described in Figure 3.1c. The assembled NPs at the interface were cross-linked by their
linkers to form microcapsules. Microcapsules were analyzed by using optical and
transmission electron microscopy (TEM). The optical microscope images showed sphereshaped microcapsules (Figure 3.2a) and crumpled NP films after drying of the oil phase
(Figure 3.2b). These results indicate that the β-CD NPs were cross-linked by the ABHex-AB moiety, forming NP films. To confirm the film formation by the host-guest
complexation in the microcapsule, we combined the α-CD NPs with AB-Hex-AD linkers
as a control experiment. While Pickering emulsions did form at the interface, the α-CD
NPs were redispersed in the water after drying of the oil phase as AB-Hex-ADs cannot
cross-link the NPs to create a film. Since the AD moiety of the linker is sterically too
large to fit into the α-CD cavity,19 inclusion complexes of the NPs at the interface did not
form and film formation did not occur. In the TEM images (Figure 3.2c, d), while the
microcapsules made of α-CD NP showed only aggregated NPs or single NPs upon drying,
the microcapsule constructed from β-CD NPs displayed a circular-shaped crumpled film
in the TEM images (Figure 3.2c, d).
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Figure 3.2 The formation of the membrane made of cross-linked NPs Microscope image
of the microcapsules made of β-CD NPs and the linker (AB-Hex-AB) (a) before and (b)
after drying of the inner phase (chloroform). Inset of (b) shows the formation of the
membrane (inset of b). (c) TEM image of the crumpled membrane made of β-CD NPs
and the AB-Hex-AB linker (d) TEM image showed only single NPs or randomly
aggregated NPs when the Pickering emulsions were made of α-CD NPs and oil including
the linker (AB-Hex-AD), indicating the absence of cross-linking by the linker.
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3.2.2 Buckling patterns of nanoparticle monolayer film crosslinked by different
binding affinities
We designed three linkers with different binding affinities to the β-CD NPs
(Figure 1a,b) to provide tunable modulation of binding affinities between the β-CD NPs.
In previous reports, adamantane moieties have been shown to have higher binding
affinities20 (ca. 52000 M-1) than benzyl groups21 (ca. 800 M-1) for β-CD. Therefore, we
hypothesize that, of our linkers, the binding affinities for the NPs would be in the order of
AD-Hex-AD>AB-Hex-AD>AB-Hex-AB. In our system, the binding environment is
complicated as the linkers have two binding sites, while the NP have many β-CD
moieties in their ligand layer, and can only interact at the oil/water interface. To probe
binding events, we directly measured the affinities between the β-CD NPs and the linkers
at the interface using isothermal titration calorimetry (ITC). In this experiment, a dilute
emulsion of oil droplets containing the linker molecule was titrated against β-CD NPs.22
The total heat change indicates the sum of heat change from the NP interactions between
the oil droplets and the linker moieties. To subtract the contribution from the heat change
from the interaction between the oil and the NPs, a titration was also conducted with
droplets devoid of any linker molecules. The results shown in Table 3.1 confirmed that
the binding affinities between the NPs and the linker have the same trend as that of their
small-molecule counterparts; AD-Hex-AD>AB-Hex-AD>AB-Hex-AB in terms of
binding affinity to β-CD NPs at the interface, (Table 3.1, and Figure 3.3)
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Table 3.1 Thermodynamic parameters of the β-CD NPs and the linkers at the interface,
as found by ITC.
Linker

ΔH
(cal mol-1)

ΔS*
(cal mol-1)

ΔG*
(cal mol-1)

K
(M-1)

AB-Hex-AB

3.30 ± 0.05 × 108

1.09 × 106

-9.01 × 103 3.21 ± 0.08 × 106

AB-Hex-AD

7.2 ± 0.2 × 107

2.39 × 105

-9.26 × 103

4.8 ± 0.2 × 106

AD-Hex-AD

3.62 ± 0.04 × 108

1.19 × 106

-9.41 × 103

6.2 ± 0.1 × 106

*The entropy change (ΔS) and the change of Gibb’s free energy (ΔG) were obtained
through calculation. K is the binding affinity of the linker to the β-CD NP on the
oil/water interface.
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Figure 3.3 ITC spectra of three droplet including the linkers titrated with β-CD
functionalized NPs. (The value of N is fixed to 1.50 × 10-4 obtained from the blank
experiment. We assumed that the same numbers of NPs were localized at the interface of
the naked droplets and the same numbers of linkers bound to a β-CD-functionalized NP.)

52

	
  

The inner phase of the capsule was replaced with a mixture of dicyclopentadiene
(DCPD), Grubbs’ catalyst, and the linker solution (5 µM AB-Hex-AB, AB-Hex-AD, or
AD-Hex-AD in chloroform; Figure 3.1c to create measurable buckling patterns for
wavelength determination.23 After the formation of the NP films at the interface of the
emulsion, the DCPD layer was polymerized to convert the capsules into stable
microparticles with buckled surfaces (Figure 3.4). Buckling of the microparticles’ surface
occurs due to the shrinkage of the inner phase, which is caused mainly by the removal of
the chloroform and the decreased volume of the polymer relative to its constituent
monomers. The buckling stress and hence the applied stress can be altered by adjusting
the volume content of chloroform. As expected, we observed the buckling morphology
depended on the amount of chloroform. Periodic buckling patterns were obtained when
the volume fraction of the chloroform was 1% (Figure 3.5). When the volume content of
the chloroform was increased to 10%, the NP films showed a crumpled structure
consistent with the application of large strains (Figure 3.6). This crumpled structure may
relate to the previous reported strain localization events.24
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Figure 3.4. SEM images of the microparticles composed of different linkers with the
buckling patterns.
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Figure 3.5 SEM images of the buckling patterns on the microparticles. The buckling
patterns of the NP films crosslinked by AB-Hex-AB (a, d), AB-Hex-AD (b,c), and ADHex-AD (c, f) obtained by polymerizing the inner phase of the microcapsules.
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Figure 3.6 SEM images of microparticles composed of different linkers showing their
crumpled structures.

We analyzed the periodic buckling morphology induced with the volume content
of chloroform of 1% since it provided a more homogeneous surface structure. Moreover,
different linkers produced different characteristic lengths of periodic buckling under this
stress condition. This result is consistent with the hypothesis that the elastic properties of
the cross-linked NP films vary depending on the chosen linker. To probe the buckling
phenomenon further, microparticles composed of α-CD NPs and AB-Hex-AD or ADHex-AD linkers were also investigated, which contained the NPs and linkers but did not
form the film (Figure 3.7). These microparticles were unable to keep their spherical shape
during the polymerization and no buckling patterns observed in their surface. From this
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control experiment, we can assume that the buckling phenomenon of the microparticle
surface is related only to the laterally supramolecularly crosslinked NP film formed
through the inclusion complexation between the NPs and linkers.

Figure 3.7 SEM images of microparticles composed of the α-CD-functionalized NPs and
inner-phase including the linkers.

3.2.3 The correlation between elastic modulus of nanoparticle monolayer film and
binding affinities between nanoparticles
From the SEM images of the buckling patterns, we observed that microparticles
fabricated from the same linker have different buckling wavelengths depending on their
radius. The observation is in agreement with Cao’s simulation study using the finiteelement method. We also found that the small microparticles do not experience sufficient
stress to form buckling structures, which is consistent with previous results of wrinkling
on a spherical substrate, and is related to the influence of curvature on the critical
buckling stress.25 From the SEM images of the microparticles, the wavelengths (d) were
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characterized in terms of the radius (R) of the microparticle. The thickness (h) of the NP
film was assumed to be 10 nm, which is the diameter of the β-CD NPs as obtained using
dynamic light scattering and estimated from the SEM image of a cracked surface of the
NP monolayer (Figure 3.8 and 3.9). The calculated values of d/R were assigned in terms
of the value R/h in Table 3.3-3.5. These data were fitted in two different ways. First, the
data were fitted with a power law with a fitting exponent b, which is found in reasonable
agreement with that predicted by Cao’s calculation (Figure 3.10 a-c; Table 3.2). We also
fit the data to Equation (2) using b from Cao’s simulated value (b=-0.8)

[15c,16a]

to

compare the value of the coefficient a and estimate the elastic modulus of each film
(Figure 3.10d). This coefficient value reflects the ratio between the elastic moduli of the
soft substrate and the stiff film. 16a,c As the same soft substrate (poly-DCPD) is used, each
value of a directly reflects the elastic modulus of each film. Notably, the trend in the
coefficient a for each film agrees with the order of the binding constants between the NPs
and linkers found earlier. This result shows the moduli of our films are successfully
controlled by binding affinities between the NPs and linkers.
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Figure 3.8 TEM image and the DLS result for β-CD-functionalized NPs.
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Figure 3.9 SEM images of microparticles composed of the β-CD-functionalized NPs and
inner phase including the linkers. The unbuckled (a,b) and buckled (c,d) surfaces of the
microparticles are covered by closed-packed NPs (ca. 10 nm). From the image of the
cracked surface of microparticle, it is confirmed that the NPs film was fabricated as NP
monolayer (white arrows indicate the single NPs)
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Table 3.2 The values of fitting parameter a for each linker molecule
Linker

a

b

a*

AB-Hex-AB
0.290 ± 0.0001
-0.790 ± 0.0001
0.40 ± 0.04
(K= 3.21 ± 0.08 × 106)
AB-Hex-AD
1.998 ± 0.0001
-0.824 ± 0.0009
1.95 ± 0.09
(K=4.8 ± 0.2 × 106)
AD-Hex-AD
6.800 ± 0.0001
-0.822 ± 0.002
6.27 ± 0.25
(K=6.2 ± 0.1 × 106)
* These values were gained by using a fixed exponent (Cao’s model: b=-0.8).
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Figure 3.10 Normalized buckling wavelength (d/R) as a function of R/h. The normalized
buckling wavelengths of the NP films cross-linked by AB-Hex-AB (a), AB-Hex-AD (b),
and AD-Hex-AD (c) were plotted in terms of normalized radius of microparticles. (d)
The fitting plots of the normalized buckling wavelengths of the NP films in log scale for
comparing each coefficient a and exponent b. Markers and lines present the experimental
values and theoretical values from Cao’s simulations, respectively.
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3.3 Summary and future outlook
In summary, we have demonstrated that the mechanical properties of ultrathin
monolayer NP films can be tuned by altering the binding affinities between NPs using
specific supramolecular interactions. The durability of the NP films can be tailored for a
particular application by adding designed linkers. More specifically, a wide range of
functional groups can be incorporated to our linkers, creating a library of linkers with
different binding affinities. By simply adding the linkers with higher binding affinities, in
situ control of the elastic modulus of NP films could be achieved, providing a general
strategy for constructing ultrathin NP composites with finely tunable mechanical
properties. These tunable surfaces have potential for the generation of new surfaces for
materials and biological interfaces.26
To clarify the relationship between the fitting parameter a and the elastic modulus
of NP monolayer film, simulation studies using the various elastic moduli and curvatures
of the substrates might need. After this simulation study, the exact meaning of parameter
a can be explained. Therefore, the precise relationship between the binding affinities and
the elastic modulus can be defined.

3.4 Synthesis of materials and experimental methods
3.4.1 Synthesis of ligand and fabrication of nanoparticle
3.4.1.1 Synthesis of CD-functionalized NP and linkers
Perthio α-/β-CD (SH- α-/β-CD) was synthesized according to reported
procedures.27 In brief, α-/β-CD-coated gold NPs (α-/β-CD NPs) were produced in the
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presence of SH- α-/β-CDs by the reduction of tetrachloroauric acid (HAuCl4) with
NaBH4.28
3.4.1.2 Synthesis of 4-Phenylazobenzoylfluoride
A suspension of 4-phenylazobenzoic acid (0.226 g, 1 mmol) and pyridine (0.162
mL, 2 mmol) in dry CH2Cl2 (5 mL) was cooled to 0°C under an argon atmosphere. To
this solution was added cyanuric fluoride (0.172 mL, 2 mmol), and the contents were
stirred for 90 min. A deep red/orange color was observed. Crushed ice/water (5 g) was
then added, the suspension filtered, and the organic layer separated and washed with cold
water (2 x 5 mL). Concentration in vacuo provided orange crystalline powder that was
used in the next step without any further purification.
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F
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N
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N
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N
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Figure 3.11 Synthesis of 4-phenylazobenzoylfluoride.

3.4.1.3 Synthesis of Adamantoyl-Hexanol (AD-Hex-ol)
The solution of Adamantane-1-carbonyl chloride (1.0 g, 5 mmol) and
triethlyamine (TEA, 1.012 g, 10 mmol) in dry 30 mL of dry CH2Cl2 was added to the
suspension of 1,6-hexanediol (2.954 g, 25 mmol) and dimethylaminopyridine (DMAP,
0.305 g, 2,5 mmol) in 30 mL dry CH2Cl2. The mixture was allowed to react for 48 h at
room temperature. The reaction mixture was extracted with 1M HCl (2 x 30 mL) and
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then H2O (3 x 30 mL). The organic phase was dried over anhydrous Na2SO4, filtered and
the volatiles were then evaporated under vacuum. The crude product was purified by
column chromatography with ethyl acetate:hexane (10:90) to yield adamantoyl-Hexanol
(AD-Hex-ol). 1H NMR spectrum (CDCl3, δ, ppm) = 4.02 (t, 2H), 3.65-3.60 (q, 2H), 1.99
(m, 3H), 1.86-1.85 (d, 6H), 1.69 (t, 6H), 1.61-1.56 (m, 4H), 1.38-1.35 (p, 4H).
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Figure 3.12 Synthesis of adamantoyl-hexanol (AD-Hex-ol).

3.4.1.4 Synthesis of 1-Adamantoyl-6-(4-phenyl)azobenzoyl-hexane (AB-Hex-AD)
The solution of 4-phenylazobenzoylfluoride (55 mg, 0.225 mmol) in 3 mL dry
CH2Cl2 was added to the suspension of 6-Adamantoyl-hexanol (56.5 mg, 0.2 mmol) and
DMAP (24.7 mg, 0.2 mmol) in 2 mL dry CH2Cl2. The mixture is stirred for 24 h. at room
temperature. After stirring, it was extracted with H2O (2 x 10 mL) and CH2Cl2 (2 x 20
mL). The organic phase was dried over anhydrous Na2SO4, filtered and the volatiles were
evaporated under vacuum. The crude product was purified by column chromatography
with ethyl acetate:hexane (10:90) to yield an orange solid product. 1H-NMR (CDCl3, δ,
ppm) = 8.18-8.16 (d, 2H), 7.95-7.92 (d, 2H), 7.53-7.51 (d, 2H), 4.34 (t, 2H), 4.05 (t, 2H),
1.98 (m, 3H), 1.86 (d, 6H), 1.83-1.77 (p, 2H), 1.69 (m, 6H), 1.65-1.62 (p, 2H), 1.51-1.41
(m, 4H).13C NMR (CDCl3, δ, ppm): 178.0, 166.3, 155.4, 152.8, 132.4, 131.9, 130.8,
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129.4, 123.4, 122.8, 65.4, 64.2, 41.0, 39.1, 36.8, 28.9, 28.8, 28.2, 26.0, 25.9, 25.8. MS
(FAB): m/z calculated for [M+H]+: 489.2755; found: 489.2734.
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Figure 3.13 Synthesis of the linker AB-Hex-AD.

3.4.1.5 Synthesis of 1,6-di(4-(phenyldiazenyl)benzoyl)-hexane (AB-Hex-AB)
The solution of 4-phenylazobenzoylfluoride (367 mg, 1.50 mmol) in 6 mL dry
CH2Cl2 was added to the suspension of 1,6-hexanediol (53 mg, 0.45 mmol) and DMAP
(73 mg, 0.6 mmol) in 4 mL dry CH2Cl2. The mixture is stirred for 24 h. at room
temperature. After stirring, it was extracted with H2O (2 x 10 mL) and CH2Cl2 (2 x 20
mL). The organic phase was dried over anhydrous Na2SO4, filtered and the volatiles were
evaporated under vacuum. The crude product was purified by column chromatography
with ethyl acetate:hexane (3:97) to yield an orange solid product. 1H-NMR (CDCl3, δ,
ppm): 8.13-8.11 (d, 4H), 7.88-7.86 (d, 8H), 7.47-7.45 (d, 6H), 4.32 (t, 4H), 1.79 (t, 4H),
1.51 (t, 4H). 13C NMR (CDCl3, δ, ppm): 166.3, 155.4, 152.8, 132.3, 131.9, 130.8, 129.4,
123.4, 122.8, 65.4, 28.9, 26.1. Anal. Calculated for C32H30N4O4: C 70.456, H 5.767, N
10.270, O 13.508. Found: C 70.218, H 5.989, N:10.615, O 13.176.
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Figure 3.14 Synthesis of the linker AB-Hex-AB.

3.4.1.6 Synthesis of Adamantane-1-carbonylfluoride
A suspension of adamantane-1-carboxylic acid (0.5 g, 2.7 mmol) and pyridine
(0.437 mL, 5.4 mmol) in dry CH2Cl2 (13.5 mL) was cooled to 0°C under an argon
atmosphere. To this was added cyanuric fluoride (0.464 mL, 5.4 mmol), and the contents
were stirred for 90 min. A deep red/orange color was observed. Crushed ice/water (13.5
g) was then added, the suspension filtered, and the organic layer separated and washed
with cold water (13.5 x 2 mL). Concentration in vacuo provided white crystalline powder
that was used in the next step without any further purification.
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Figure 3.15 Synthesis of adamantane-1-carbonylfluoride.
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3.4.1.7 Synthesis of 1,6-diadamantoylhexane (AD-Hex-AD)
The solution of adamantane-1-carbonylfluoride (99 mg, 0.5 mmol) in 6 mL dry
CH2Cl2 was added to the suspension of adamantoylhexanol (112 mg, 0.4 mmol) and
DMAP (49 mg, 0.4 mmol) in 4 mL dry CH2Cl2. The mixture is stirred for 24 h. at room
temperature. After stirring, it was extracted with H2O (2 x 10 mL) and CH2Cl2 (2 x 20
mL). The organic phase was dried over anhydrous Na2SO4, filtered and the volatiles were
evaporated under vacuum. The crude product was purified by column chromatography
with hexane to yield a white solid product. 1H-NMR (CDCl3, δ, ppm) = 4.02 (t, 4H), 1.99
(m, 6H), 1.86 (d, 12H), 1.69 (t, 12H), 1.61 (p, 4H), 1.36 (p, 4H).

13

C NMR (CDCl3, δ,

ppm): 178.0, 64.2, 41.0, 39.1, 36.8, 28.8, 28.2, 25.8. MS (FAB): m/z calculated for
[M+H]+: 443.3163; found: 443.3146.
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Figure 3.16 Synthesis of the linker AD-Hex-AD.
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3.4.2 Experimental methods
3.4.2.1 Preparation of the microcapsules for optical microscopy
To fabricate the microcapsules, α-/β-CD NP solutions (10 µM β-CD NPs in H2O)
and oil including the linkers (5 µM linkers in chloroform) were prepared. To 1.5 mL of
the NP solution, 100 µL of the linker/oil solution were added and rapidly agitated.
Microcapsules were produced and precipitated due to the density of the chloroform. To
wash out the excess NPs, 1 mL of solution was decanted and the same amount of milli-Q
water was added. This washing process was repeated 3-4 times. The microcapsules were
characterized by using optical microscopy (Olympus IX-51) and TEM (JEOL CX-100).
3.4.2.2 ITC measurement
Isothermal titration calorimeter (ITC) experiments were performed at 30°C using
a MicroCal VP-ITC instrument. Oil droplets (5 µM linkers in chloroform) were generated
by agitating the mixture of 10 µL of oil in 490 µL of milli-Q water without any NPs.
Each microcalorimetric experiment consisted of 50 successive injections of a 2 µL
solution of 10 µM β-CD NPs into the reaction cell containing 1.4 mL of oil droplets
including each linkers. A blank experiment without the linkers was carried out as a
control. The final titration curves were obtained by subtracting the control enthalpies
from the sample enthalpies.
3.4.2.3 Preparation of the buckled microparticle
To form buckling patterns, a method similar to one for fabricating the
microcapsule was used. However, the oil solution was changed from chloroform to a
mixture of 95 µL of the 5 µM linker in DCPD and 5 µL of 1.5%(w/w) first-generation
Grubbs catalyst in chloroform. In brief, 5 µL of the oil mixture was added to 495 µL of
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the NP solution (10 µM in H2O). Then, the solution was agitated by a homogenizer
(speed 5000 rpm for 1-2 s). After 4 h, the inner phase was completely polymerized. The
solutions were drop-casted onto a silicon wafer and dried for 24 h under ambient
conditions for SEM measurement. A JEOL JSM 6320F SEM was used for this
experiment.
3.4.2.4 Application of Cao’s model
To plot d/R vs. R/h, data was extracted from the SEM images (Table 3.3-3.5 and
Figure 3.17 – 3.38). The diameter (2R) was determined by averaging five measurements
and the wavelengths (d) were measured as the averaged spacing between the lowest
points of neighboring buckles from the SEM images using Image J software. Power-law
relationship fittings were carried out at both fixed (-0.8) and unfixed values of b.

Table 3.3 Various values of d/R depending on the values of R/h in the microparticles
composed of the AB-Hex-AB linkers.
AB-Hex-AB
image #

R/h

S.D.(R/h)

d/R

S.D.(d/R)

#1

138.23389

4.9672871

0.016204637

0.001762922

#2

61.7509

0.578417845

0.022448499

0.001585749

#3

108.30811

4.559272352

0.017583817

0.001728647

#4

82.98596

1.055981852

0.020256981

0.003103911

#5

81.54808

1.52656136

0.020092319

0.001824705

#6

173.65532

2.5724871

0.016161929

0.002810976
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Image #1
1
2
3
4
5
Average
Radius

Diameter
2847.339
2646.48
2719.456
2886.815
2723.299
2764.6778
1382.3389

Image #1
1
2
3
4
5
6
7

Wavelength
22.179
19.617
20.946
25.958
25.227
22.06
21.124

S.D.

49.672871

8

22.06

9
10
11
12
13
14
15
16
17
18
19

18.518
20.946
24.135
19.212
20.182
22.026
26.88
23.538
25.093
21.283
23.933

20

23.089

Average
S.D.

22.4003
2.3001820

Average
(d/R)

0.016204637

S. D. (d/R)

0.001762922

#1

Figure 3.17 The value of d/R and the radius of the microparticle composed of AB-HexAB linkers from SEM image #1.
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Image #2
1
2
3
4
5
Average
Radius
S.D.

Diameter
1228.438
1236.824
1254.229
1230.581
1225.018
1235.018
617.509
5.784178453

#2

Image #2
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

Wavelength
14.92
13.06
14.638
14.541
14.041
13.736
13.987
12.529
13.849
15.462
14.234
15.007
14.845
13.711
12.747
13.81
12.05
13.06
14.008
13.008
13.86215
0.905770755

Average
(d/R)

0.022448499

S.D. (d/R)

0.001481809

Figure 3.18 The value of d/R and the radius of the microparticle composed of AB-HexAB linkers from SEM image #2.
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Image #3
1
2
3
4
5
Average
Radius
S.D.

Diameter
2269.567
2100.348
2170.752
2052.001
2238.143
2166.1622
1083.0811
45.59272352

#3

Image #3
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

Wavelength
19.016
18.432
20.981
19.122
17.432
16.788
17.376
17.039
20.392
18.041
18.291
18.377
18.291
19.6
24.194
17.039
18.824
18.222
20.392
20.041
19.0447
1.691939936

Average
(d/R)

0.017583817

S.D.(d/R)

0.001728647

Figure 3.19 The value of d/R and the radius of the microparticle composed of AB-HexAB linkers from SEM image #3.
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Image #4
1
2
3
4
5
Average
Radius
S.D.

Diameter
1672.239
1663.416
1686.204
1637.823
1638.914
1659.7192
829.8596
10.55981852

#4

Image #4
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

Wavelength
12.935
19.282
21.446
21.21
17.268
17.257
17.759
18.224
16.182
15.223
15.973
19.402
15.522
15.656
16.489
14.462
19.787
11.839
16.11
14.183
16.81045
2.566912552

Average
(d/R)

0.020256981

S.D.(d/R)

0.003103911

Figure 3.20 The value of d/R and the radius of the microparticle composed of AB-HexAB linkers from SEM image #4.
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Image #5
1
2
3
4
5
Average
Radius
S.D.

Diameter
1614.446
1625.999
1668.121
1592.077
1654.165
1630.9616
815.4808
15.2656136

#5

Image #5
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

Wavelength
16.01
16.876
19.014
16.401
20.282
17.109
16.652
16.231
14.063
16.352
16.072
17.52
14.479
16.604
16.509
16.616
15.094
14.369
15.873
15.572
16.3849
1.456057109

Average
(d/R)

0.020092319

S.D.(d/R)

0.001824705

Figure 3.21 The value of d/R and the radius of the microparticle composed of AB-HexAB linkers from SEM image #5.
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Image #6
1
2
3
4
5
Average
Radius
S.D.

Diameter
3502.064
3441.588
3499.163
3398.903
3523.814
3473.1064
1736.5532
25.724871

#6

Image #6
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

Wavelength
23.799
29.61
21.449
23.501
25.216
27.678
25.087
23.593
21.076
35.016
37.745
23.163
31.749
33.914
32.089
32.359
26.279
33.088
28.028
26.882
28.06605
4.863670516

Average
(d/R)

0.016161929

S.D.(d/R)

0.002810976

Figure 3.22 The value of d/R and the radius of the microparticle composed of AB-HexAB linkers from SEM image #6.
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Table 3.4 Various values of d/R depending on the values of R/h in the microparticles
composed of the AB-Hex-AD linkers.
AB-Hex-AD
image #

R/h

Stdv(R/h)

d/R

Stdv(d/R)

#7

85.46616

4.348917472

0.065200835

0.006687877

#8

66.84316

2.731984478

0.076192089

0.009942082

#9, #10

66.72924

4.724364627

0.075044463

0.012734324

#11, #12

184.5207

13.42746652

0.041601755

0.006505563

#13, #14

120.76362

5.702248073

0.050591478

0.0047888

#15

64.89466

2.423910545

0.078659169

0.011952579

#16

75.23311

2.29966144

0.072473808

0.009165507

#17

120.26083

13.7778451

0.051434495

0.009698906
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Image #7
1
2
3
4
5
Average
Radius
S.D.

Diameter
1842.928
1697.16
1645.611
1623.287
1737.63
1709.3232
854.6616
43.48917472

#7

Image #7
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

Wavelength
57.549
45.064
53.378
57.068
65.576
50.811
50.22
54.727
53.378
57.269
52.325
54.147
58.616
64.722
58.938
50.822
58.624
61.677
54.698
54.884
55.72465
4.962958533

Average
(d/R)

0.065200835

S.D.(d/R)

0.006687877

Figure 3.23 The value of d/R and the radius of the microparticle composed of AB-HexAD linkers from SEM image #7.
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Image #8
1
2
3
4
5
Average
Radius
S.D.

Diameter
1355.64
1416.295
1305.925
1271.133
1335.323
1336.8632
668.4316
27.31984478

#8

Image #8
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

Wavelength
57.107
54.233
54.233
50.649
49.19
58.381
39.216
56.191
54.113
64.572
54.946
51.131
47.466
44.383
42.418
41.048
49.137
46.123
53.922
50.125
50.9292
6.311192577

Average
(d/R)

0.076192089

S.D.(d/R)

0.009942082

Figure 3.24 The value of d/R and the radius of the microparticle composed of AB-HexAD linkers from SEM image #8.
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Image #9,10

Diameter

1
2
3
4
5
Average
Radius

1327.098
1482.73
1229.116
1285.641
1348.339
1334.5848
667.2924
47.243646
2

S.D.

Image
#9,10
1
2
3
4
5
6
7

#9

Wavelength
41.191
46.763
48.704
41.191
56.611
52.75
54.404

8

52.571

9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.
Average
(d/R)
S.D.(d/R)

52.821
61.801
59.406
54.404
58.704
60.693
45.357
45.729
34.738
42.633
39.347
51.714
50.0766
7.722572726
0.075044463
0.012734324

#10

Figure 3.25. The value of the d/R and
the radius of the microparticle
composed of AB-Hex-AD linkers
from SEM images #9 and #10.
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Image
#11, 12
1
2
3
4
5
Average
Radius
S.D.

Image
#11,12
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.
Average
(d/R)
S.D.(d/R)

Diameter
3773.803
3342.021
4023.748
3809.052
3503.446
3690.414
1845.207
134.2746652

#11

Wavelength
76.298
59.585
77.847
75.26
80.499
66.569
73.98
90.139
95.015
91.667
77.083
79.276
91.001
76.83
75.289
67.604
79.55
80.039
70.032
51.714
76.76385
10.62518716
0.041601755
0.006505563

#12
Figure 3.26 The value of d/R and the
radius of the microparticle composed of
AB-Hex-AD linkers from SEM images
#11 and #12.
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Image
#13,14
1
2
3
4
5
Average
Radius
S.D.

Image
#13,14
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.
Average
(d/R)
S.D.(d/R)

Diameter
2357.312
2526.381
2293.852
2351.309
2547.508
2415.2724
1207.6362
57.02248073

#13

Wavelength
63.805
58.046
65.489
60.371
64.371
61.684
60.496
66.224
57.602
62.729
64.47
61.395
54.332
61.613
70.677
52.174
67.724
51.883
61.266
55.571
61.0961
5.012205722
0.050591478
0.0047888

#14

Figure 3.27 The value of d/R and the
radius of the microparticle composed
of AB-Hex-AD linkers from SEM
images #13 and #14.
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Image #15
1
2
3
4
5
Average
Radius
S.D.

Diameter
1310.536
1350.939
1315.115
1219.742
1293.134
1297.8932
648.9466
24.23910545

#15

Image #15
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

Wavelength
59.755
48.637
43.236
43.339
37.792
58.852
38.942
50.621
49.233
49.53
53.936
44.006
61.658
59.438
45.137
60.679
61.624
51.729
52.355
50.413
51.0456
7.518602708

Average
(d/R)

0.078659169

S.D.(d/R)

0.011952579

Figure 3.28 The value of d/R and the radius of the microparticle composed of AB-HexAD linkers from SEM image #15.
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Image #16
1
2
3
4
5
Average
Radius
S.D.

Diameter
1492.79
1536.193
1453.556
1566.321
1474.451
1504.6622
752.3311
22.9966144

#16

Image #16
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

Wavelength
51.22
49.69
39.588
50.137
46.849
52.411
59.288
60.661
48.609
59.085
55.556
50.85
61.558
59.085
58.94
55.06
48.077
60.914
53.99
68.918
54.5243
6.691048499

Average
(d/R)

0.072473808

S.D.(d/R)

0.009165507

Figure 3.29 The value of d/R and the radius of the microparticle composed of AB-HexAD linkers from SEM image #16.
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Image #17
1
2
3
4
5
Average
Radius
S.D.

Diameter
2794.644
2104.506
2529.988
2190.562
2406.383
2405.2166
1202.6083
137.778451

#17

Image #17
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

Wavelength
54.194
66.974
56.884
61.47
72.582
69.411
57.032
57.765
68.557
73.988
50.663
63.887
70.583
73.217
43.466
75.48
47.518
57.749
59.206
56.485
61.85555
9.264401298

Average
(d/R)

0.051434495

S.D.(d/R)

0.009698906

Figure 3.30 The value of d/R and the radius of the microparticle composed of AB-HexAD linkers from SEM image #17.
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Table 3.5 Various values of d/R depending on the values of R/h in the microparticles
composed of the AD-Hex-AD linkers.
AD-Hex-AD
image #

R/h

Stdv(R/h)

d/R

Stdv(L/R)

#18

168.45644

3.331034023

0.103790392

0.004905531

#19, #20

246.48392

3.238083654

0.079548901

0.007693427

#21

171.28212

2.053057826

0.105438268

0.006147481

#22

156.88339

2.42590913

0.11416591

0.02750209

#23

142.44883

4.150787885

0.120947255

0.016977347

#24, #25

194.4163

4.347369103

0.093701068

0.006908858

#26

183.09545

3.242880869

0.097768869

0.004997992

#27

233.26228

5.817664275

0.082526223

0.004660982

86

	
  

Image #18
Diameter
1
3463.865
2
3348.666
3
3286.127
4
3346.733
5
3400.253
Average
3369.1288
Radius
1684.5644
S.D.
33.31034023

Image #18
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

#18

Wavelength
170.537
177.617
168.25
173.946
184.426
182.565
181.85
170.488
174.794
178.492
171.359
165.291
176.15
178.222
192.952
171.265
160.247
176.178
178.953
163.25
174.8416
7.50570378

Average
(d/R)

0.103790392

S.D.(d/R)

0.004905531

Figure 3.31 The value of d/R and the radius of the microparticle composed of AD-HexAD linkers from SEM image #18.
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Image
#19, 20
1
2
3
4
5
Average
Radius
S.D.

Image
#19, 20
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.
Average
(d/R)
S.D.(d/R)

Diameter
4953.939
4925.792
4861.837
4881.15
5025.674
4929.6784
2464.8392
32.38083654

#19

Wavelength
199.683
204.249
219.261
210.367
192.373
197.163
196.352
226.469
183.8
193.8
200.731
219.731
174.161
215.692
219.967
182.871
154.8
186.209
176.789
181.576
196.07525
18.78730016
0.079548901
0.007693427

#20

Figure 3.32 The value of d/R and the radius
of the microparticle composed of AD-HexAD linkers from SEM images #19 and #20.
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Image
#21
1
2
3
4
5
Average
Radius
S.D.

Diameter

Image #21

Wavelength

3442.667
3471.516
3369.107
3398.656
3446.266
3425.6424
1712.8212
20.53057826

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

184.944
181.532
178.07
186.77
197.537
172.54
182.316
193.361
172.597
173.947
191.907
173.131
178.659
186.992
185.185
168.082
151.041
188.101
175.924
189.302
180.5969

#21

10.3046191

Average
(d/R)

0.105438268

S.D.(d/R)

0.006147481

Figure 3.33 The value of d/R and the radius of the microparticle composed of AD-HexAD linkers from SEM image #21.
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Image
#22
1
2
3
4
5
Average
Radius
S.D.

Diameter

Image #22

Wavelength

3189.992
3068.752
3129.897
3121.816
3177.882
3137.6678
1568.8339
24.2590913

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

228.496
246.501
195.727
191.82
136.654
157.104
185.789
169.323
225.888
239.459
221.735
249.701
139.491
157.261
154.382
115.604
115.364
129.476
141.927
180.445
179.10735

#22

43.0572294

Average
(d/R)

0.11416591

S.D.(d/R)

0.02750209

Figure 3.34 The value of d/R and the radius of the microparticle composed of AD-HexAD linkers from SEM image #22.
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Image
#23
1
2
3
4
5
Average
Radius
S.D.

Diameter

Image #23

Wavelength

2881.9
2796.079
2733.346
2893.119
2940.439
2848.9766
1424.4883
41.50787885

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

169.535
177.778
171.436
102.213
214.321
211.877
169.82
181.028
171.144
172.58
185.447
167.037
174.448
186.67
153.081
151.586
186.608
191.506
167.244
140.4
172.28795

#23

23.65722631

Average
(d/R)

0.120947255

S.D.(d/R)

0.016977347

Figure 3.35 The value of d/R and the radius of the microparticle composed of AD-HexAD linkers from SEM image #23.
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Image
#24, 25
1
2
3
4
5
Average
Radius
S.D.

Image
#24, 25
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.
Average
(d/R)
S.D.(d/R)

Diameter
3895.504
3871.977
3772.238
4016.527
3885.384
3888.326
1944.163
43.47369103

#24

Wavelength
182.168
199.603
185.146
171.153
185.453
162.39
187.825
179.254
189.626
187.313
187.667
159.468
165.413
197.148
191.88
171.717
179.626
161.144
199.626
199.783
182.17015
12.79935601
0.093701068
0.006908858

#25
Figure 3.36 The value of d/R and the
radius of the microparticle composed
of AD-Hex-AD linkers from SEM
images #24 and #25.
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Image
#26
1
2
3
4
5
Average
Radius
S.D.

Diameter

Image #26

Wavelength

3682.64
3671.05
3570.77
3747.903
3637.182
3661.909
1830.9545
32.42880869

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

172.562
172.397
185.45
183.45
173.191
173.206
195.411
186.452
192.348
178.023
166.248
185.45
185.526
166.884
167.357
177.191
173.275
187.626
171.45
186.71
179.01035

#26

8.584306182

Average
(d/R)

0.097768869

S.D.(d/R)

0.004997992

Figure 3.37 The value of d/R and the radius of the microparticle composed of AD-HexAD linkers from SEM image #26.
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Image
#27
1
2
3
4
5
Average
Radius
S.D.

Diameter

Image #27

Wavelength

4718.717
4618.203
4499.695
4811.938
4677.675
4665.2456
2332.6228
58.17664275

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Average
S.D.

197.025
181.734
197.94
180.344
188.471
208.09
182.375
184.127
200.825
188.696
183.312
194.759
188.989
218.673
192.163
187.37
180.607
194.646
198.673
201.232
192.50255

#27

9.754825434

Average
(d/R)

0.082526223

S.D.(d/R)

0.004660982

Figure 3.38 The value of d/R and the radius of the microparticle composed of AD-HexAD linkers from SEM image #27.
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CHAPTER 4

NANOPARTICLE DENDRIMER HYBRID NANOCAPSULES FOR IN VIVO
DRUG DELIVERY
4.1 Introduction

Two-dimensional porous structures offer a pliable platform for controlling
molecular interactions. 1 , 2 , 3 Porous nanomaterials have been used in a variety of
applications such as catalysis, 4 , 5 bio-molecules separation, 6 , 7 and drug delivery. 8 , 9
Permeable architectures create geometrically restrictive environments for controlling
structure-substrate interactions.10,11 This behavior can be tuned through modulation of
pore size as well as of structure surface functionalities. 12 , 13 , 14 , 15 Furthermore, the
properties of the components used to generate the porous matrix can be readily
incorporated into the overall functionality of the system.16,17
Translating the behavior of two-dimensional porous structures into functional,
nanometer- sized three-dimensional structures is challenging. The most commonly used
approach is to confine the assembly of inorganic precursors and porogens into
nanometer-sized templates.18 Mesoporous silica nanoparticles have been widely used as
nanosized structures with tunable permeability.19,20 For example, Zink and Stoddart have
demonstrated that directed supramolecular assemblies can be used to control the release
of encapsulated cargo from mesoporous silica nanoparticles.21,22,23,24 Supramolecularbased assembly methods are particularly attractive for generating porous materials as the
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assembly is self-sorting and creates discrete structures.25,26 Taken together, controlling
the dimensions and payload interactions at the surface of permeable carriers is crucial to
improve the performance of porous nanomaterials.
Previously, we have demonstrated that synthetic biomimetic membranes provide
an effective way to control the release of payloads from two-dimensional therapeutic
reservoirs. 27, 28 We hypothesized that these thin film membranes could be wrapped
around an interfacial core to form a permeable drug delivery vehicle. Herein, we describe
the fabrication of three-dimensional, porous nanostructures through the self-assembly of
nanoparticles and dendrimers at the surface of therapeutic oil droplets. This multimodal
self-assembly is driven by therapeutic emulsions acting as three-dimensional templates
for the vehicles’ overall structure.

In our design, cationic gold nanoparticles self-

assemble at the surface of the oil droplets complex and are covalently crosslinked by
anionic dithiocarbamate functionalized dendrimers generating a porous film at the
oil/water interface (Figure 4.1). The release behavior and stability of the nanoparticle
dendrimer hybrid nanocapsules (NDHCs) was controlled by adjusting the molar ratio
between dendrimer linkers and nanoparticles. This superimposed membrane approach
was used to create structures with a high payload to carrier ratio that was shown to be an
effective in vivo drug delivery vehicle.
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Figure 4.1 Schematic illustration of formation of (a) dithiocarbamate functionalized
dendrimers and (b) NDHCs. The dithiocarbamate functionalized dendrimers as
crosslinkers were fabricated by the interfacial reaction between PAMAM dendrimer and
CS2 and the crosslinkers bound to the cores of nanoparticles, forming the nanoparticledendrimer composite film at the interface. (c) A TEM image of the dried NDHC. (d) A
SEM images of the dried NDHC.
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4.2 Results and discussion
4.2.1 Fabrication of nanoparticle-dendrimer hybrid nanocapsules (NDHCs)
Our previous study demonstrated that arginine functionalized gold nanoparticles
(Arg-AuNPs) can effectively stabilize ~100 nm sized linoleic acid emulsions to form
stable therapeutic capsules.29 To enhance the utility of the vehicles, we hypothesized that
by tuning the lateral interactions between nanoparticles at the oil/water interface we could
modulate the stability and drug release behavior of the capsules. Furthermore by using
the emulsion as a template for directing the crosslinking with dithiocarbamate
functionalized dendrimers robust nanoparticle-polymer composite films should assemble
at the interface. The assembly strategy is depicting in Figure 4.1.

First, the

dithiocarbamate functional dendrimers were synthesized through the reaction of
poly(amido

amine)

(PAMAM)

dendrimers

and

CS2 in

a

biphasic

system

(water:dichloromethane, pH=10, Figure 1a). After synthesizing the crosslinkers,
nanoparticle-stabilized Pickering emulsions (NSPEs, diameter=100 nm) were fabricated
separately and then incubated with the crosslinkers to form nanoparticle-dendrimer
hybrid capsules (NDHC) (Figure 4.1b). Transmission electron microscopy (TEM) and
scanning electron microscopy (SEM) indicate that the NDHCs can preserve a stable
three-dimensional structure after drying and their original sizes (~ 100 nm) (Figure
4.1c,d). We hypothesized that the rate of drug release could be regulated by the molar
ratio between nanoparticles and dendrimer linkers or the generation of dendrimers like
the two-dimensional nanoparticle-dendrimer films.
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Maintaining the size of a colloidal delivery vehicle is paramount if it is to harness
the enhanced permeation and retention effect. In order to maintain the nanometer sized
capsules while introducing the dendrimers’ functionality, we first set out to determine the
effect the Arg-AuNP:dendrimer ratio would have on the size of the capsules. As shown in
Figure 4.2, when the AuNP:dendrimer molar ratio was below 1:16, the diameter of the
NDHCs remained fairly constant (100 nm), regardless of the generation of the dendrimer
crosslinker used (generation 2 or 4). We assumed that a molar ratio of the dendrimer
linker to nanoparticle exceeding 1:16 caused inter-capsule crosslinking. These
observations demonstrated that the NDHCs could be fabricated in the range from 1 to 16
of dendrimer molar concentrations and preserve capsule size.

Figure 4.2 The diameters of the NDHCs fabricated by various molar ratios when
generation 2 dendrimers (a) and generation 4 dendrimers (b) were used.
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4.2.2 Stability of nanoparticle-dendrimer hybrid nanocapsules (NDHCs)
Long term stability of capsules dictates how the vehicle will perform in biological
applications.

We investigated the stability of NDHCs fabricated by various

concentrations and generations of dendrimers to determine the optimal conditions. To
probe the colloidal stability of the NDHCs, the diameter of NDHCs in sodium phosphate
buffer (5 mM, pH 7.4) was monitored after 24 h of incubation (Figure 4.3). While the
diameter of NDHCs fabricated by using second-generation dendrimer linkers was
increased, fourth-generation dendrimer linkers provided excellent stability regardless of
the concentration of the linkers. We assumed that the fourth-generation (G4) dendrimer
linkers would provide more linkages between the Arg-AuNPs with their larger size
allowing their functional groups to reach the gold cores more effectively than secondgeneration (G2) dendrimer linkers creating a more stable vehicle. Based on this result, a
fourth-generation dendrimer linker was chosen for the fabrication of NDHCs for
subsequent drug delivery studies.
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Figure 4.3 The diameters of the NDHCs fabricated by AuNP:Dendrimer(G2 and G4) 1:1,
1:4, and 1:16 in water before / after 24 h.
We next probed the degree to which the molar ratio of G4 dendrimer:Arg-AuNP
would affect the stabilities of the capsules. To remove the interfacial tension between
linoleic acid and water and disrupt the capsule structure, 20 % v/v of ethanol was added
to the NDHCs solutions, and the diameters of the NDHCs fabricated by various
dendrimer molar ratios (Arg-AuNPs:dendrimer linker; 1:1, 1:4, and

1:16) were

monitored in terms of incubation time. While the diameters of the NSPEs increased as a
function of time, the diameters of the NDHCs were preserved (Figure 4.4 a,c, Figure 4.5).
To confirm these results, TEM images of the NDHCs and the NSPEs after 24 hour of
incubation in water/ethanol were obtained. As shown in Figure 3b the NDHCs could
preserve their shape and size, whereas only nanoparticle aggregates were observed in the
TEM image, Figure 3d, of the NSPEs. Additionally, the stability of the NDHCs in the
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presence of surfactant molecules (sodium dodecyl sulfate, 0.1M) was monitored. Unlike
for the NSPEs, the diameter of the NDHCs was preserved (Figure 4.6). These results
strongly suggest that the Arg-AuNPs were densely crosslinked at the interface and this
crosslinking formed a nanoparticle dendrimer composite shell. The stability of NDHCs
in biological condition (DMEM media with 10% serum) was monitored via checking the
hydrodynamic diameter. During the 18 h, the NDHCs (1:4, G4 dendrimer) could preserve
their shape and size, showing their biological stability (Figure 4.4e).
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Figure 4.4 (a) The diameter of the NDHCs fabricated by AuNP:dendrimer(G4) 1:4 in
water/ethanol (8:2.v/v) in terms of incubation time. (b) The TEM image of NDHCs after
24 h incubation in water/ethanol (8:2, v/v). (c) The diameter of the NSPEs in
water/ethanol (8:2.v/v) in terms of incubation time. (d) The TEM image of NSPEs after
24 h incubation in water/ethanol (8:2, v/v). (e) The diameter change of the NDHCs
fabricated by AuNP:dendrimer(G4) 1:4 in DMEM media with 10 % serum for 18 h.
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Figure 4.5 The diameter of the NDHCs fabricated by AuNP:Dendrimer(G4) 1:1 and 1:16
in water/ethanol (8:2.v/v) in terms of incubation time.

Figure 4.6 The diameter of the NDHCs before / after the incubation of 0.1 M SDS
solution.
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4.2.3 Controlled drug release of nanoparticle-dendrimer hybrid nanocapsules
(NDHCs)
Control over payload release is crucial to use the capsule structure as a drug
delivery carrier. NDHCs fabricated by different molar ratios of G4 dendrimer linker were
explored to control the drug release profile. As we hypothesized, applying different
dendrimer linker molar ratios affected the drug release profile of the NDHCs. Higher
molar ratios of dendrimer linkers provided an environment in which the hydrophobic
drugs (paclitaxel (PTX)) tend to remain in the shell of the NDHCs, decreasing drug
release (Figure 4.7). Therefore, the drug release profile of the NDHCs can be tuned
simply by tuning the dendrimer linker molar ratio.
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Figure 4.7 Drug release profiles of NDHCs fabricated by using different dendrimer
molar ratios in terms of time. Higher molar ratio of dendrimer reduced the rate of drug
release than lower molar ratio. Through the control of the molar ratio of dendrimer, the
drug release profile can be simply tuned.
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4.2.4 Mechanism of drug release of nanoparticle-dendrimer hybrid capsules
(NDHCs)
To visualize the delivery cross-sectional cell-TEM images of B16F10 and MCF-7
cells incubated for 3 h with NDHCs or NSPEs were obtained. The NDHCs could
preserve their shape and size after being taken up by cells (Figure 4.8 a-c). However,
TEM images of the cells incubated with NSPEs showed only nanoparticle aggregates
(Figure 4.8d). Significantly, Figure 4.8e shows the early process of endocytosis of
nanoparticle aggregates, indicating that the NSPEs were converted to nanoparticle
aggregates before the capsules had been taken up by cells. These results indicate that
NDHCs are stable and can protect their cargos during the cellular uptake process. To
tracking the cargo and carrier during the cellular uptake process, we first encapsulated the
fluorescent dye (Nile red) into NDHCs and treated in B16F10 and MCF-7 cells in terms
of incubation time (30, 60, 360 min). Cytoflow metry and inductively coupled plasma
mass spectroscopy (ICP-MS) were used for tracking the intensity of released dye and
amount of gold inside cells, respectively. The NSPEs treated cells were also investigated
for comparison. In the NDHCs treated cells, the ratio between the intensity of the
fluorescence and the gold amount was relatively constant regardless of the incubation
time while the result of the NSPE treated cells showed the fluctuation of the ratio
depending on the incubation time (Figure 4.9, 4.10). In previous studies, we suggested
that NSPE used the membrane fusion mechanism for delivery, showing the cargos first
delivered to the cells and the carriers slowly were uptaken by the cell.29, 30. Unlike
NSPEs, NDHCs were taken up by cells and the dyes were then released from the carrier.

112

	
  

The enhanced stability and controlled drug release of NDHCs changed the delivery
pattern, preventing premature release of drugs before the carrier arrives at the target sites.

Figure 4.8 (a, b) TEM images of cross-sectional B16F10 cells incubated for 24 h with
NDHCs, (c) TEM images of cross-sectional MCF-7 cells incubated for 24 h with (a)
NDHCs and (d,e) NSPEs.
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Figure 4.9 The mean value of fluorescence intensity of cells treated with (a) NSPEs or
(c) NDHCs. The mean values were obtained by flow cytometry. Quantification of the
amount of gold present in cells treated with (b) NSPEs or (d) NDHCs. Samples were
analyzed by ICP-MS to determine the amount of gold in B16F10 cells after various
incubations.
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Figure 4.10 The mean value of fluorescence intensity of cells treated with (a) NSPEs or
(c) NDHCs. The mean values were obtained by flow cytometry. Quantification of the
amount of gold present in cells treated with (b) NSPEs or (d) NDHCs. Samples were
analysed by ICP-MS to determine the amount of gold in MCF-7 cells after various
incubations.
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4.2.5 Nanoparticle-dendrimer hybrid nanocapsule (NDHC) as a drug carrier
Based on the drug release and stability results, we chose the NDHCs fabricated by
G4 dendrimer linker with 1:4 molar ratio (NP: G4 dendrimer). Cytotoxicity of both
NDHCs and PTX-loaded NDHCs was evaluated in mammalian cancer cells such as
MCF-7 and B16F10 cells using Alamar Blue assay. Using a cell viability assay, NDHC
showed no cytotoxic effect on mammalian cells (Figure 4.11). However, the PTX (10
mg/mL)-loaded NDHCs showed an anticancer effect to both cancer cell types. These
results demonstrate that the NDHC itself could be a potential drug carrier, capable of a
high-loading efficiency of PTX due to its oil core and could effectively deliver PTX to
any type of cancer cells.

Figure 4.11 Cytotoxicity of NDHCs and PTX-loaded NDHCs measured by Alamar blue
assay after 24 h incubation in (a) B16F10 and (b) MCF-7 cells. No cytotoxicity of
NDHCs was observed up to 0.3 nM of NDHCs. However, the PTX-loaded NDHCs
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showed the Cell viability experiments were performed as triplicate and the error bars
represent the standard deviations of these measurements.
The antitumor effect of PTX-loaded NDHC was evaluated in a B16F10
melanoma tumor model. C57BL6 mice were treated with PBS, PTX, the NDHC or PTXloaded NDHC. As a result, PTX-loaded NDHC significantly inhibited tumor growth
compared to the PTX-treated group, indicating that the NDHCs possess the ability to
passively target tumors (Figure 4.12). Tumor volume showed no increase after the second
administration of the PTX-loaded NDHC, but the mice in the control groups including
the PBS treated group, PTX treated group, and NDHCs without drug loading group
showed a rapid increase of tumor volume (2-3 times). In the comparison of volume
change of tumor of PTX treated group and PTX-loaded NDHCs treated group, the PTX
treated group showed a rapid increase in spite of the same dose of PTX while the PTXloaded NDHCs showed the inhibition effect of tumor glow. This result indicates that the
NDHCs possess the passive targeting ability. Moreover, the body weight of mice in the
four groups remained unchanged throughout the experiment (Figure 4.13), indicating
there is no significant side effect. These data demonstrate that NDHC effectively
delivered hydrophobic PTX to the melanoma tumor site, creating an antitumor effect
based on the enhanced permeation and retention effect.
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Figure 4.12 Relative tumor volume in mice injected with the NDHCs, PTX-loaded
NDHCs, PTX in PBS, and PBS (n = 5, mean±sem).

Figure 4.13 Body weight change of mice injected with the NDHCs, PTX-loaded
NDHCs, PTX in PBS, or PBS (n = 5, mean ± standard deviation).
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4.3 Summary and future outlook
In summary, we have developed a new type of nano-sized drug delivery carrier
having a nanoparticle-dendrimer composite shell and an oil core. By transferring a twodimensional nanoparticle-dendrimer composite film to a three-dimensional capsule
structure, the resulting materials provide controlled drug release, stability, and therapeutic
efficacy in vivo. The drug release of these NDHCs can be tuned by modulating the
NP/dendrimer molar ratio. This interaction controlled the drug release profile and their
stability can affect the drug release mechanism, preventing premature release of the
drugs. The NDHCs act as a drug carrier for cancer therapy in vivo, displaying efficient
therapeutic and passive targeting ability.
The versatility of these NDHCs can be further enhanced through incorporation of
targeting components into their nanoparticles or dendrimer linkers, providing an effective
platform for drug delivery systems. These stable NDHCs also can be used in protein
delivery or siRNA delivery. Furthermore, more functions such as on-demand drug release
and thermal therapy can be added in this system replacing gold nanoparticle to gold
nanorod.
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4.4 Synthesis of materials and experimental methods
4.4.1 Fabrication of the dithiocarbamate (DTC)-functionalized dendrimer linker
To synthesize the dendrimer linker, 8.8 mM of PAMAM dendrimer in a NaOH
solution (pH ~10, 3mL) were mixed with 500 µL of CS2 in dichloromethane (3 mL). The
mixture was stirred for 4 h at room temperature. After stirring, the linker was obtained at
the water layer. DTC functionalization was confirmed by checking for color change in
the presence of Cu2+ ion (Figure 4.14).

Figure 4.14 The formation of the DTC copper complexes. To check the formation of the
dithiocarbamate function of dendrimer linker, the Cu2+ was added to the water layer
before (a) / after (b) stirring for 4 h. The DTC functional group and Cu ion spontaneously
formed complexes, changing the solution color from blue to green.
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4.4.2 Fabrication of the NDHCs
To prepare the NDHCs, 2.0 µL of linoleic acid was emulsified in 1 mL of
arginine-functionalized nanoparticles (1.0 µM) in a phosphate buffer solution (5.0 mM,
pH 7.4) using an amalgamator (speed 5000 rpm for 200s). This process results in oil
droplets having a 12.8 nM concentration. Next, 200 µL of the 6.4 nM droplets were
incubated with arginine nanoparticles (5 µM) in 800 µL phosphate buffer (5.0 mM, pH
7.4) for 10 min. Finally, the nanocapsules were cross linked by the dithiocarbamate
functionalized dendrimers (12.8 nM for 1:1 ratio, 51.2 nM for 1:4 ratio, and 204.8 nM for
1:16 ratio) for 12h. To fabricate the PTX loaded NDHCs , 10 mg / mL PTX in linoleic
acid for in vitro or 50 mg / mL PTX in linoleic acid for in vivo drug release was used.
4.4.3 TEM sample preparation
TEM samples of the NDHCs or the NSPEs were prepared by placing one drop of
the desired capsule solution (1 nM) on a 300-mesh Cu grid coated with carbon film.
These samples were analyzed and photographed using a JEOL CX-100 Electron
microscope.
4.4.4 SEM sample preparation
SEM samples of the NDHCs were prepared by placing several drops of the
desired capsule solution (1 nM) on a clean silicon wafer and then dried for 24h under
ambient conditions. After drying, the samples were coated with platinum via sputtering
for SEM imaging. A FEI Magellan 400 High-Resolution Scanning Electron microscope
was used for this experiment.
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4.4.5 DLS measurements
The size of the NDHCs or the NSPEs was measured by Dynamic Light
Scattering. To evaluate the stability of the capsules, 20 % ethanol or 1 M SDS was added
to the solutions. The size of the capsules was measured on a Malvern Zetasizer Nano ZS
instrument.
4.4.6 In vitro release of paclitaxel
After fabricating the NDHCs with different ratios of NP to dendrimer, each
NDHC was first added to a dialysis cassette (Side-A-Lyzer® 3.5K, Thermoscientific, IL).
Each dialysis cassette with the NDHCs was placed in a dark glass chamber with 30 mL of
phosphate buffered saline (PBS, pH 7.4). The release experiment was performed at
steady state conditions of 37°C and 100 rpm (Lab-Line® Orbit Environ-Shaker, Lab-Line
Instruments, Inc.) for 3 days. At given time intervals, each supernatant (0.3 mL) of three
different NDHC formulations was taken and then resuspended in 25% acetonitrile after a
drying

process

(VacufugeTM,

Eppendorf,

Germany).

Each

supernatant

was

quantitatively analyzed by a high-performance liquid chromatography system (DGU20AS, Shimadzu, Japan). Separation was achieved using C18 reverse phase column
(ODS, 4.6 mm x 250 mm) under a mobile phase consisting of two eluents, 0.1%
trifluoroacetic acid (TFA) in H2O and 0.1% TFA in ACN (68:32, v/v). The flow rate was
1 mL/min and the injection volume was 20 µL. Released paclitaxel was detected at 273
nm using an ultraviolet (UV) detector (SPD-20AV).
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4.4.7 Cell culture and cellular uptake experiment
B16F10 and MCF-7 cells (American Type Culture Collection (ATCC)) were
cultured at 37°C, 5% CO2 in a humidified atmosphere (MCO-18AC, Panasonic, Japan).
Each cell type was grown in low glucose Dulbecco’s Modified Eagle’s Medium (DMEM,
Gibco®, VA) supplemented with 10% fetal bovine serum and 1% antibiotic antimycotic
solution (100 U/mL penicillin, 100 µg/mL streptomycin and 0.25 µg/mL amphotericin
B). For subculture, cells were harvested by trypsin-EDTA solution (Cellgro, VA) before
confluency and transferred to a new 75 cm, 2-canted neck flask.
Both B16F10 and MCF-7 cells had been previously seeded in each 48 well-plate
(5×104 cells/well) one day prior to a drug release mechanism experiment. Then, either
NDHCs or NSPEs incorporating Nile red dye was added to the cells and incubated for
different times (30, 60 and 360 min). At given time intervals, the cells were washed three
times with PBS (pH 7.4) and trypsinized for flow cytometric anaylsis (BD LSR II, BD
bioscience).
In addition, B16F10 cells (1.8 x 105 cells/dish) were also cultured in glassbottomed dishes (MatTeck Corporation, 14 mm microwell) one day prior to confocal
microscopy. The next day, NDHCs incorporating the Nile red dye were incubated with
the cells for 1 hr. Then, the cells were washed with PBS three times before taking a
confocal image. Confocal microscopy images were assessed with a Zeiss LSM 510 Meta
microscope using a 63x objective and the red channel (Ex=543 nm, Em=long pass 650
nm) was used for detecting the Nile red dye.
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4.4.8 Sample preparation for flow cytometry
B16F10 and MCF-7 cells were cultured using Dulbecco's Modified Eagle's
Medium (DMEM, 1 mL) and plated in 12-well microplates with a density of 40,000
cells/well and the cells were grown for 24 hours. The Nile red encapsulated NSPEs or
NDHCs in DMEM media were then added and incubated for 0.5, 1, and 6 h,
respectively.. The media of the cells was removed and the cells washed with PBS (3×) to
eliminate any extracellular capsules. After completing incubation, the cells were washed
twice with PBS, harvested with trypsin/EDTA and resuspended in 2% FCS in PBS
buffer. These samples were analyzed by BDTM LSR II.
4.4.9 Cytotoxicity
Cytotoxicity was assessed by an AlamarBlue® assay (Invitrogen, USA)
incorporating an oxidation-reduction indicator based on detection of metabolic activity.
Briefly, B16F10 and MCF-7 cells had been previously cultured in a 48 well plate (5x104
cells/well), respectively. Then, each cell was incubated with either NDHC or NDHCPTX for 1 day. Following incubation, the cells were washed with PBS and treated with
10% Alamar blue dye in a low glucose DMEM medium with 10% fetal bovine serum.
After incubation, fluorescence intensity was measured (Ex: 560 nm, Em: 590 nm) using a
SpectroMax M2 microplate reader (Molecular devices, CA) to determine cell viability.
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4.4.10 Inductively coupled plasma mass spectrometry (ICP-MS) analysis
After cellular uptake of NDHC or NPSC, the lysed cells were digested by 0.5 mL
of fresh aqua regia (N.b. Highly corrosive aqua regia must be added with extreme
caution!) for 1 hr. Each digested sample was mixed with an internal standard 103Rh (10
ppb) and diluted to 10 mL with double-distilled water (ddH2O). A series of gold standard
solutions ranging from 20 to 0 ppb was prepared prior to each experiment. Each gold
standard solution also contained 5% aqua regia as well as 10 ppb of
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Rh. ICP-MS

analyses were performed on a Perkin-Elmer NexION 300X ICP mass spectrometer as
follows: nebulizer flow rate: 0.95-1 L/min; rf power: 1600 W; dwell time: 50 ms.
4.4.11 Cross-sectional cell TEM
Cellular TEM images of the NSPEs and the NDHCs were obtained using a JEOL
CX-100 electron microscope. All the cell TEM samples were prepared according to the
literature.31 Briefly, MCF-7 and B16F10 cells were seeded and incubated on 15-mmdiameter Theramanox coverslips (Nalge Nunc International) in 24-well plates (100,000
cells per well) with 1 mL of serum containing media for 24 h before the treatment of the
NSPEs or the NDHCs. The media was replaced by the NSPEs or the NDHCs in serum
containing media and incubated for 3 h. The media containing NSPEs or the NDHCs was
exchanged with new media, and the MCF7 and B16F10 cells were washed three times
with PBS buffer. The cells treated with NSPEs or NDHCs were then fixed in 2 %
glutaraldehyde with 3.75% sucrose in 0.1 M sodium phosphate buffer (pH 7.0) for 30
min and washed with 0.1 M PBS containing 3.75% sucrose, three times over 30 min. The
fixed cells were postfixed in 1% osmium tetroxide with 5% sucrose in 0.05 M sodium
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phosphate buffer solution (pH 7.0) for 1 hour and then washed with DI water three times.
Then, the postfixed cells were dehydrated in a graded series of acetone (10% steps) and
embedded in epoxy resin. The resin was polymerized at 70 °C for 12 h. Ultrathin sections
(70 nm) were obtained with a Reichert Ultracut E Ultramicrotome and then imaged under
a JEOL CX-100 electron microscope.
4.4.12 Animal Care
All animal experiments were conducted in accordance with the guidelines of
Institutional Animal Care and Use Committee (IACUC) at University of MassachusettsAmherst. Female C57BL6 mice (8-10 weeks, 20-25 g) were purchased from Jackson
Laboratory (Bar Harbor, ME). Food and water intake were assessed.
4.4.13 Intravenous administration of the NDHC in melanoma tumor-induced mice
After one week of acclimatization, female C57BL/6 mice were anesthesized
intraperitoneally by Avertin (tribromoetheanol, Acros, 200 mg/kg). Then, B16F10 cells
(50 µL, 2x105 cells) were inoculated subcutaneously in the right flank after removing hair
with a trimmer (Braintree Scientific, MA). After the tumors were allowed to grow to over
100 mm3, mice were randomly rearranged and divided into the following groups: control
group (saline), paclitaxel (PTX, 1 mg/kg dose)-treated group, the NDHC-treated group,
and PTX-loaded NDHC-treated group. Each agent sample was intravenously
administered every other day for 10 days after inducing the melanoma tumor. Changes in
mouse weight were monitored and tumor volumes were measured by an electric digital
caliper.
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CHAPTER 5

SOLUBILIZATION OF HYDROPHOBIC CATALYSTS USING
NANOPARTICLE HOSTS

5.1 Introduction
Transition metal-mediated catalysis in aqueous media is of great interest as it
diminishes the dependence on environmentally harmful organic solvents.1 Furthermore,
using water as a safe, low-costing, and non-toxic reaction medium2 reduces economic
burden on chemical industries. 3 However, most catalytic reactions are performed in
organic solvents due to limited solubility,4 activity, and stability5 of the catalysts in water.
Therefore, designing a general platform that solubilizes various hydrophobic catalysts in
water while preserving their activity and stability, and bringing sustainability remains
critical for environmental and economical benefits.
Covalent and non-covalent modifications to transition metal (TM) catalysts have
been used to improve catalyst solubility in aqueous environments. The most widely
investigated approaches to increase the aqueous solubility of TM catalysts are covalent
conjugation of the catalysts with hydrophilic ligands6 or anchoring charged substituents
to the coordinating hydrophobic ligands.7 These covalent modifications demand specific
ligand designs for each catalyst which has been shown to affect the stability and
reactivity of the native catalyst.8 Host–guest assembly of catalysts with cyclodextrins,9
calixarenes,10 and cucurbiturils,11 have been shown as effective non-covalent methods to
solubilize catalysts without the need to alter the structure of the catalysts. 12 These
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supramolecular approaches are limited by their necessity for the catalysts to possess
suitable guest molecules within their native ligand structure.13
Improving the solubility of TM catalysts does not inherently protect the catalysts
from aqueous degradation. Covalent modification has been shown to change the steric
and electronic environment of metal center which subsequently can weaken the bond
between the water soluble ligand and the metal resulting in poor initiation efficiency, 5a
decomposition of catalyst,14 and loss of activity.15 Supramolecular based assemblies such
as micelles have been shown to maintain catalytic efficiency.16 However, the dynamic
nature of micelle based systems requires fine tuning of surfactant concentration to ensure
concentrations over their critical micelle concentration 17 and removal of excess
surfactants after reaction is non-trivial for these water soluble platforms.18 Therefore the
creation of a robust, generalized platform for improving catalyst solubility and stability is
desired.
Here, we present a facile and general method to solubilize and stabilize
hydrophobic TM catalysts while conserving catalytic activity using a water soluble gold
nanoparticle (AuNP) platform. A water soluble NP host was designed bearing two crucial
features: an aliphatic interior to create hydrophobic pockets for catalyst encapsulation
and a water soluble exterior for aqueous solubility.19 In our method, there is no need for
covalent modification of the catalyst, which leads to a retention of the original catalyst
structure and activity. Furthermore, our supramolecular template supplies a protective
niche for hydrophobic catalysts while the large surface area of the NP increases the
accessibility of substrates to catalysts. We have studied different hydrophobic catalysts,
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catalyzing three commercially important reactions to show the versatility of our
supramolecular-based platform.

Figure 5.1 (a) The encapsulation process of hydrophobic catalysts in water soluble NP
hosts. (b) Schematic illustrating catalytic reaction within NP monolayer.
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5.2 Results and discussion
5.2.1 Encapsulation of hydrophobic catalysts in various nanoparticles and their
encapsulation yield
Hydrophobic TM catalysts were encapsulated using a solvent displacement
method that is an effective and simple method followed previously to entrap hydrophobic
drugs or dyes.19 Water soluble NP hosts and hydrophobic TM catalysts as guest
molecules were dissolved in acetone/water or tetrahydrofuran/acetone/water mixtures and
then the organic solvents were allowed to evaporate slowly. During the evaporation
process, some of TM catalysts were encapsulated into the hydrophobic pockets in the
monolayer of AuNP host and formed the catalyst-encapsulated nanoreactors (AuNP-cat),
while excess hydrophobic catalysts were precipitated out. First, multiple filtrations were
performed to remove non-entrapped catalysts using molecular weight cutoff filters and
then, further purification was done through dialysis against water (Figure 5.1a).
Entrapment of hydrophobic catalysts in the hydrophobic regions of water soluble AuNPs
provides the catalyst aqueous solubility, while preserving catalytic activity. Mixing
substrates with AuNP-cat yielded products in water (Figure 5.1b). Here, AuNP serves
two roles: a water soluble host for hydrophobic catalysts and a nanoreactor for catalytic
reactions.
Two different sized gold cores (2 and 7 nm), each with two different ligand
structures (TTMA and TMA, Figure 5.2a) were investigated to fabricate an efficient host
platform with a high encapsulation profile. Both TTMA and TMA ligands posses a
hydrophobic chain, crucial for hydrophobic pocket formation and a charged ammonium
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head group for water solubility. However, the TTMA ligand is longer because of the
tetraethylene glycol (TEG) unit appearing before the head group (Figure 5.2a).
Qualitative confirmation of catalyst presence in the monolayer of NP hosts was
monitored by 1H-NMR in D2O after encapsulation and washing steps. Peaks observed at
around 6.8-7.8 ppm demonstrate that 2nd generation Hoveyda-Grubbs catalysts (HG2)
were entrapped inside the NP host (Figure 5.3).
Loaded catalyst amount in the monolayer of NP was calculated by tracking TM
ions using KCN-induced decomposition experiments19 followed by inductively coupled
plasma mass spectrometry (ICP-MS) measurements. The results indicate that 7 nm core
NP hosts can hold more catalysts, however, 2 nm core NPs shows higher encapsulation
yield according to weight ratio between catalyst and NP core (Figure 5.2b). When same
core size but different ligand structure was considered, NP bearing TEG groups showed a
higher catalyst loading efficiency. The surface ligand coverage was obtained using the
laser desorption/ionization mass spectrometry20 to probe the effect of ligand coverage on
encapsulation yield. The results revealed that the TTMA AuNPs possess more remaining
pentane thiols after place exchange reaction than TMA AuNPs do, indicating that the
pentane thiols provide a larger space to encapsulate the catalysts (Figure 5.4). Based on
ICP-MS results, 2 nm core sized TTMA NP host is the most efficient one among other
NP hosts, therefore, catalytic reactions were performed using 2 nm TTMA NPs (Figure
5.2b).
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Figure 5.2 (a) The structure of NP hosts (core 2 and 7 nm) and the structure of TTMA
and TMA ligands. (b) The encapsulation efficacy of various NP hosts that have different
core sizes and monolayer structure for HG2.
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Figure 5.3 (a) Structure of the TTMA functionalized AuNP, (b) NMR spectrum of HG2
catalyst encapsulated AuNP, (c) Enlarged section of NMR spectrum in the range from 6
to 8 ppm.

Figure 5.4 Ion intensity ratio of TMA and TTMA coated 2 and 7 nm AuNPs
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The aggregation of NPs during the encapsulation and intense purification steps
can be an issue for the stability of the nanoreactor. The size of the NP host was monitored
before and after encapsulation of HG2 as well as after the purification process by
transmission electron microscopy (TEM). TEM images showed no size change or
aggregation of the NP host-HG2 compared to the NP host, displaying the stability of the
nanoreator (Figure 5.5).

Figure 5.5 TEM images of HG2 catalyst encapsulated AuNPs
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5.2.2 Ring opening metathesis polymerization in water using the NP Host-HG2
Our initial catalysis studies focused on commercially available HG2 catalyst, one
of the most used hydrophobic catalysts for ring opening metathesis polymerization
(ROMP). In our system, ROMP was performed in neat water by using 2 nm TTMA
AuNP-HG2 catalyst and a positively charged norbornene monomer21 (Figure 5.6a-b).
After 24 hours, white suspension was observed as an indication of polymer formation.
However, when the exact same conditions except no catalyst encapsulated in the AuNPs
was used, the solution mixture stayed clear and polymer generation was not detected
(Figure 5.7). Effect of reaction time on polymerization was monitored by using gel
permeation chromatography (GPC). Polymers collected at different time points were
characterized in terms of molecular weight and PDI (polydispersity index) (Figure 5.6d).
Results show a typical linear trend of living polymerization that molecular weight
increases with elevated reaction time. Narrow PDI values were obtained as expected
from a living ROMP reaction, indicating that our AuNP-HG2 system supplies the fine
molecular weight control (Figure 5.6c-d and 5.11).
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Figure 5.6 (a) The structure of 2nd generation Hoveyda-Grubbs catalyst (HG2) and HG2
encapsulated NP hosts (NP Host-HG2). (b) The reaction scheme of ROMP using NP host
and water soluble monomer. (c) The molecular weight and PDI values of polymers in
terms of reaction time. (d) While the free HG2 in acetone/water mixture failed to produce.

140

	
  

Figure 5.7 Photos of the reaction mixtures including (a) NP Host or (b) NP Host-HG2
after 24 h reactions.

Catalysts containing ruthenium carbene complexes in their structure generally
decompose quickly in aqueous solvents22 and consequently, they are unable to catalyze
ROMP reactions. In the literature, to understand the mechanism, NMR spectroscopy was
used to follow this decomposition process of HG2 catalyst in water/THF solutions and
results indicated that instability originated from water coordination at ruthenium in the
methylidene-propagating species.22 We have checked the stability of free HG2 catalyst
and found that in the presence of monomer and free HG2 catalyst in 1:1 acetone/water
mixture, the reaction failed to produce any polymer. Therefore, GPC could only detect
the unreacted monomer at various reaction time points (Figure 5.6d and 5.12). However,
HG2 catalyst embedded into the monolayer of AuNPs successfully catalyzed the ROMP
reaction under same conditions (Figure 5.6d). From these results, we deduce that our NP
hosts can provide a protective environment blocking water molecules from coordinating
to metal center and as a result prevent decomposition.
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5.2.3 Allycarbarmate cleavage using the NP host that encapsulates Cp*Ru(cod)Cl
As a model catalyst that can catalyze cleavage reactions, the hydrophobic
[(pentamethylcyclopentadienyl) Ru(1,5-cyclooctadiene)Cl] catalyst (Cp*Ru(cod)Cl) was
chosen for the cleavage of allylcarbamate bonds (Figure 5.8b).23 We have quantified that
there are 22.7 ± 1.9 Cp*Ru(cod)Cl catalysts per one NP host (Figure 5.9). Rhodamine
110 is a green fluorescent dye with amine functionality that can be protected with
allylcarbamate. After caging, Rhodamine 110 becomes nonfluorescent, however, upon
allycarbamate deprotection, strong green fluorescence is recovered as an indication of
catalytic cleavage (Figure 5.8b and d). Reaction activity was monitored using UV
absorbance of the Rhodamine 110 dye at a wavelength of 500 nm. While absorbance
increased linearly in the presence of substrate (Rhodamine 110 derivative) and AuNPCp*Ru(cod)Cl, it stayed constant when only AuNP and substrate were used.
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Figure 5.8 (a) The structure of Cp*Ru(cod)Cl catalyst. (b) The reaction scheme of
ruthenium-induced allylcarbarmate cleavage using NP hosts and non-fluorescent
Rhodamine 110 derivative. (c) Catalytic activity of NP host- Cp*Ru(cod)Cl and only NP
host. (d) Photographs of the reaction mixtures under UV-irradiation.
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Figure 5.9 Quantification of encapsulated catalyst in the 2 nm TTMA-AuNP.

5.2.4 Hydrogenation using the NP host that encapsulates Wilkinson catalysts and
their reuability
Another type of reaction we have studied for the AuNP host encapsulation
process is the hydrogenation of alkenes. The complex RhCl(PPh3)3 (also known as
Wilkinson’s catalyst) is a hydrophobic, highly active catalyst for hydrogenation reactions.
We encapsulated Wilkinson catalyst into the AuNP host and ICP-MS detected 29.7 ± 6.9
catalysts per NP host (Figure 5.9). 0.7 mole percent of NP-Wilkinson catalyst were
reacted with sodium 4-vinylbenzenesulfonate in water under hydrogen (3 atm) at room
temperature for various reaction times (Figure 5.10a-b and 5.13). Reactions were
monitored by NMR; after hydrogenation, the alkene peaks coming between 5.2-6.8 ppm
in the NMR spectrum disappear while triplet and quartet peaks appear due to the
formation of ethyl group. The integration of those peaks was used to calculate conversion
percentage of the hydrogenation. Results show ~100% conversion after 24 hours of
reaction (Figure 5.10c and 5.14). These hydrogenation experimental conditions prove the
AuNP-cat system can effectively catalyze not only monophasic water solvent systems
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(ROMP reaction and allylcarbamate bond breakage) but also gas-water biphasic systems
(hydrogenation reaction).
Catalytic reusability is an important factor in catalyzed reactions for industrial
applications. We have examined the reusability of AuNP host-catalyst system for
hydrogenation reaction. After the first reaction, a molecular weight cutoff filter (10 k)
was used to separate AuNP-Wilkinson catalyst and 4-ethylbenzenesulfonate. AuNPWilkinson catalyst was recovered after three times washing and reacted again with
substrate sodium 4-vinylbenzenesulfonate under the same conditions (room temperature,
3 atm). This cycle repeated up to five times and 100% conversion was obtained as a proof
of recyclability the of NP-catalyst template (Figure 5.10d).

Figure 5.10 (a) The structure of Wilkinson catalyst. (b) The reaction scheme of
hydrogenation using NP host and sodium 4-vinylbenzenesulfonate. (c) Hydrogenation
conversion profile in terms of reaction time for AuNP-Wilkinson. (d) Reusability test of
AuNP-Wilkinson system for five consecutive cycles.
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5.3 Summary and future outlook
In summary, we have developed a versatile NP-based platform for the
encapsulation of hydrophobic catalysts. This supramolecular system is amenable to
catalyzing a multitude of reactions in aqueous environments without the need to
specifically tailor the host’s structure for each hydrophobic catalyst. The functionalized
monolayer of the NP host serves as a phase transfer agent for the catalyst while
concurrently preventing catalyst ‘drowning’ through supramolecular stabilization.
Future studies will explore the use of this platform in biological systems and as
multifunctional catalytic reactors. For example, these water-soluble catalysts can deliver
into living cells, catalyzing the bioorthogonal reactions. Though these bioorthogonal
reactions, we can control the bioprocesses or treat many diseases.

5.4 Synthesis of materials and experimental methods
5.4.1 Materials and Instruments
All chemicals and materials for the experiments were obtained from Aldrich or
Fisher Scientific. Reaction activities were monitored by a microplate reader (Molecular
Device SpectroMax M2) for fluorescent product (Rhodamine 110). NMR spectroscopy
(Bruker AVANCE 400 at 400 MHz) for hydrogenation and THF GPC (Agilent
Technologies 1260 Infinity) for ROMP reactions were used.
5.4.2 Synthesis of TMA and TTMA coated AuNPs
Pentanethiol-coated AuNPs with core diameter ca. 2 nm 24 and 7 nm 25 were
synthesized by following Brust-Schiffrin two-phase method. AuNPs were decorated with
TTMA or TMA ligands using Murray place-exchange method.26 For each place exchange
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reaction, 2nm or 7 nm AuNPs (10 mg) was mixed with 27 mg of TTMA or TMA ligands
in dry dichloromethane (DCM) for 3 days at room temperature. After reaction, solvent
was evaporated and mixture was washed with hexane and DCM and then dialyzed
against water.
5.4.3 Encapsulation of the catalysts
Catalysts (Grubbs, Cp*Ru(cod)Cl, or Wilkinson catalysts) and AuNPs were
dissolved in an acetone/water or tetrahydrofuran/acetone/water mixture and then the
acetone and tetrahydrofuran was slowly evaporated. During this process, most of the
catalysts were encapsulated in monolayers and the excess hydrophobic catalysts
precipitated.

After removing the precipitate via filtration using syringe filter (pore

size=0.2 µm), multiple washings using a molecular-weight cutoff filter (10K) and dialysis
against water were performed to remove all free catalysts.
5.4.4 Quantification of the catalysts
Quantification of catalyst in the monolayer of AuNPs was achieved by doing the
ICP-MS analyses performed on a Perkin-Elmer NexION 300X ICP-MS spectrometer.
197

Au,

102

Ru, and

103

Rh were measured under the standard mode. Operating conditions

are listed as below: nebulizer flow rate: 0.95 L/min; rf power: 1600 W; plasma Ar flow
rate: 18 L/min; dwell time: 50 ms. Standard gold, ruthenium, and rhodium solutions
(concentration: 0, 0.2, 0.5, 1, 2, 5, 10, and 20 ppb) were prepared for the quantification.
For the sample preparation for quantification of gold, Ruthenium, and Rhodium, Aqua
regia (0.5 mL) was added to the sample solution (10 uL) and then the sample was diluted
to 10 mL with de-ionized water.
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5.4.5 ROMP reaction in water by using AuNP-HG2
HG2 catalyst encapsulated 2 nm TTMA NPs (520 nM) was mixed with positively
charged norbornene monomer (6 mM) in a final volume of 3 ml water. Polymerization
reaction was monitored for various time intervals (1, 4, 6, 24 h) and THF GPC was used
to calculate molecular weights and PDI values of polymers.
5.4.6 Allyl carbamete bond cleavage reaction by using AuNP- Cp*Ru(cod)Cl
Cp*Ru(cod)Cl encapsulated 2 nm TTMA NPs (194 nM) was mixed with caged
Rhodamine 110 (220 µM) in a final volume of 1 ml water. Green fluorescence of
Rhodamine 110 was observed as result of catalytic allycarbamate deprotection reaction.
UV absorbance of the Rhodamine 110 at a wavelength of 500 nm wavelength was
monitor for reaction activity.
5.4.7 Hydrogenation of sodium 4-vinylbenzenesulfonate via AuNP-Wilkinson
catalyst
Wilkinson catalyst encapsulated 2 nm TTMA NPs (23 µM, 1.2 mL) was mixed
with sodium 4-vinylbenzenesulfonate (2.3 mg, 0.8 mL) in water under 3 atm H2 at room
temperature. Reactions were monitored by NMR for various time intervals (1, 3, 6, 24, 48
h). For the reusability test, same conditions were applied.
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5.4.8 Laser desorption/ionization mass spectrometry (LDI-MS) Instrumentation:
The surface ligand coverage comparison was done using the previous reported
LDI-MS method.20 The mixed disulphide ions were formed by TTMA/TMA ligand and
original alkanethiol ligand. Higher amount of remaining alkanethiol ligands result in
higher ion intensity ratio between the mixed disulphide ion and the intensity sum of
TMA/TTMA ligand and mixed disulphide ion. The quantification data was acquired on a
Bruker Autoflex III MALDI-TOF mass spectrometer (Bruker Daltonics, Bremen,
Germany) (Autoflex III). Operating conditions were as follows: ion source 1 = 19.00 kV,
ion source 2 = 16.60 kV, lens voltage = 8.44 kV, reflector voltage = 20.00 kV, reflector
voltage 2 = 9.69 kV, pulsed ion extraction time = 10 ns, suppression = 100 Da, and at
positive reflectron mode. Molecular ion and mixed disulphide ion from each molecule
has been chosen as quantification ion in the data analysis, for example: TTMA (m/z 422),
TMA (m/z 246), TTMA-C5 (m/z 524), and TMA-C5 (m/z 348). 40 mass spectra have
been acquired for each sample, and each mass spectrum represents an average of 200
laser shots.
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Figure 5.11 GPC spectra of the polymers that were synthesized by ROMP in water at
different time intervals (1, 4, 6, and 24 h).
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Figure 5.12 GPC spectra of reactions that were performed using free catalysts in
acetone/water mixture at different time intervals (1, 4, 6, and 24 h).
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Figure 5.13 NMR spectra of the hydrogenation reactions in water at the different times
(1, 3, 6, 24, and 48 h).
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Figure 5.14 NMR spectra of hydrogenation reactions for recyclability test, yielding 4ethylbenzenesulfonate as the final product. All of samples were measured after 24 h
reaction.
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CHAPTER 6

ALLOSTERICALLY-CONTROLLED BIOORTHOGONAL CATALYSIS IN
CELLS USING NANOPARTICLE-EMBEDDED TRANSITION METAL
CATALYSTS

6.1 Introduction
Bioorthogonal chemistry1 is a promising strategy for the intracellular generation
of molecules for therapeutic2 and imaging applications3 unattainable through naturally
occurring bioprocesses.4 Transition metal catalysts (TMCs) are excellent candidates for
use in bioorthogonal processes, 5 rapidly catalyzing transformations that cannot be
performed via enzymatic processes. 6 However, the application of TMC-mediated
reactions in living cells is challenging due to issues of biocompatibility, water solubility,
catalyst stability, and rapid efflux of catalyst from living cells.
Loading of TMCs into nanomaterial scaffolds can be used to provide water
solubility and a protective environment for TMCs. Bradley et al.5c and Unciti-Broceta et
al.6b used palladium-catalyst loaded polystyrene beads to catalyze reactions such as
allylcarbamate cleavage and Suzuki-Miyaura coupling inside cells. The particles used in
these studies, however, were far larger than normal proteins, creating potential
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interference in cellular processes. Additionally, these particles did not provide the
capability of allosteric regulation, a key component in cellular homeostasis.7
In our research we have developed a family of gold nanoparticles (AuNPs) based
on ~2 nm core size8 that feature biomimetic size, possess diverse functional properties,9
and are efficiently transport of into cells.10 We report here the use of the AuNP structural
motif to encapsulate11 hydrophobic TMCs, providing NP_Ru (Figure 6.1) The resulting
nanozymes12 feature surface functionality that can be reversibly functionalized using
host-guest chemistry to provide NP_Ru_CB[7]. 13 Complexation of the monolayer
terminal functionalities by cucurbit[7]uril (CB[7])14 in this system blocks access to the
catalytic site, resulting in essentially complete inhibition of catalytic activity. The
gatekeeper molecules15 can then be released from the AuNPs using competitive guests,16
restoring catalytic activity (Figure 6.1). The efficacy of this system was demonstrated in
solution and in cells through the gated generation of a fluorophore through deallylation of
a non-fluorescent precursor.
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Figure 6.1 Bioorthogonal nanozyme. (a) Particles used in study (b) Endosomal uptake of
nanozymes. (c) Intracellular catalysis with NP_Ru. (d) CB[7] complexation with the
ligand headgroup to provide NR_Ru_CB[7] inhibits catalyst activity (e) Nanozyme
activity is restored through addition of the competitive guest ADA (f) Structures of the
NP platform, CB[7] gatekeeper, and ADA. (g) Structures of the non-fluorescent substrate,
fluorescent product, and embedded catalyst

160

	
  

6.2 Results and discussion
6.2.1 Encapsulation of ruthenium catalysts in nanozymes
We used AuNPs with core diameters of ~2 nm as the scaffold for our catalysts,
with the goal of creating protein-sized systems with functional monolayers. The
monolayer coverage of the NP nanoreactor scaffold features three crucial components: 1)
a hydrophobic alkane segment for catalyst encapsulation, 2) a tetra(ethylene glycol) unit
to provide biocompatibility,17 and 3) a dimethylbenzylammonium group to impart water
solubility and bind the non-toxic CB[7] gatekeeper (Figure 6.1d).18
We chose ruthenium-catalyzed deallylation19 as a model bioorthogonal process.
To this end, we immobilized [Cp*Ru(cod)Cl] (Cp* = pentamethylcyclopentadienyl, cod
= 1,5-cyclooctadiene) in the hydrophobic portion of the AuNP monolayer to provide
NP_Ru. Transmission electron microscopy (TEM) images of the AuNPs before and after
encapsulation of the catalyst indicated that no aggregation or decomposition of AuNP
structure occurred after encapsulation (Figure 6.2), a result that was confirmed by
dynamic light scattering. The amount of catalyst relative to AuNP was quantified using
inductively coupled plasma mass spectrometry (ICP-MS, Figure 6.3)20 of
to 197Au, with 42 ± 3 catalyst molecules encapsulated per AuNP.
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Figure 6.2 TEM images of benzyl-AuNP with (a) without (b) encapsulation of the
catalysts.

Figure 6.3 Ruthenium amount in the nanozyme using ICP-MS measurement.
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6.2.2 Catalytic efficacy of nanozymes in water
The catalytic efficacy of the NP_Ru nanozymes in solution was assessed using
the allylcarbamate cleavage of bis-N,N’-allyloxycarbonyl rhodamine 110 (Figure 6.1e).
After 24 h bright fluorescence was observed using the nanozymes (Figure 6.4a). As
expected no reaction occurred with the control particle that lacked embedded catalysts
(Figure 6.5). Likewise, no catalysis was observed [Cp*Ru(cod)Cl] alone due to lack of
aqueous solubility.

Figure 6.4 Catalytic activity of nanozymes. (a) Fluorescence generation by NP_Ru and
NP_Ru_CB[7] and (b) activity after adding ADA, (c) The reaction rates of the nanozyme
and the nanozyme-CB before and after adding ADA (d) Photo of the reaction mixture
with NP_Ru and NP_Ru_CB[7] under UV light.
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Figure 6.5 Reaction mixtures including (a) the nanozyme and caged Rhodamine 110 and
(b) Benzyl-AuNP and caged Rhodamine 110 after 24 h.

6.2.3 Inhibition mechanism of the nanozymes
The analogy between allosteric regulation of the nanozymes and their enzyme
counterparts was explored through kinetic analysis of the nanozymes using Lineweaver–
Burk analysis (LBA). 21 These studies indicate that CB[7] complexation results in
competitive inhibition of reactor activity (Figure 6.6 and 6.7), presumably by blocking
access to the [Cp*Ru(cod)Cl] "active site". Little change in activity was observed for
CB[7]:NPs ratios greater than ~80:1, consistent with the ITC results (Figure 6.8, 6.9,
6.10). Likewise, the value of Ki from the LBA (11.4±4.3 mM) is essentially identical to
the affinity obtained by ITC (11.3±2.4 mM). Taken together, these studies demonstrate
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the direct correlation between CB[7]-AuNP equilibrium binding processes and kinetic
behavior of the nanozyme.

Figure 6.6 Lineweaver-Burk plot. Kinetic studies of NP_Ru and NR_Ru_CB[7] indicate
that CB[7] inhibits catalyst activity through a competitive inhibition mechanism, with
CB[7] affinity and stoichiometry consistent with ITC binding studies.
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Figure 6.7 The dependence of reaction rates on the concentration of the substrates (a,0
µM; b, 4 µM; c, 16 µM; and d, 80 µM). (e) The fitting curve of the reaction rate vs.
concentration of the substrates
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Figure 6.8 The dependence of reaction rate on the concentration of CB[7].

Figure 6.9 The reaction rate titration curve
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Figure 6.10 ITC titration of CB[7]s into the nanozyme solution. The circles represent the
integrated heat changes during complex formation and the lines represent the curve fit to
the binding isotherm.

6.2.4 Cellular uptake of the nanozymes and their cytotoxicity
Having characterized the activity and gating of NP-Ru/NP_Ru_CB[7] catalysis
in solution, we next studied the intracellular behavior of these nanozymes using HeLa
cells. The cellular uptake of the nanozymes was quantified by tracking [197Au] using ICPMS, with NP_Ru_CB[7] particles demonstrating a slightly more efficient (1.7-fold
greater) uptake than uncomplexed NR-Ru (Figure 6.11). Significantly, little to no
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toxicity was observed at the concentrations used for our studies with NR, NR_Ru, or
NR_Ru_CB[7]. (Figure 6.12).

Figure 6.11 Nanozyme uptake assay by tracking the gold amount through ICP-MS.

Figure 6.12 Cytotoxicity of the nanozyme with and without the catalyst.
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6.2.5 Catlytic activity of the nanozymes inside the living cells
We then probed the catalytic activity of the nanozymes inside the living cells.
HeLa cells were incubated with the nanozyme for 24 h and then washed multiple times to
remove adsorbed particles on the cell surface. Fresh media containing the substrate was
added, followed by 24 h incubation and washing. As shown in Figure 5.13a, flow
cytometry indicated that there was a significant increase in fluorescence with NR_Ru
relative to the control NR. Confocal microscopy (Figure 6.13d) showed that the cells
treated with NR_Ru had bright punctate fluorescence. This fluorescence co-localized
with LysoTracker® (Figure 6.14), indicating that the deallylation reaction occurred in the
endosomes. This outcome is expected given the endosomal uptake pathway22 previously
observed for similar nanoparticles, coupled with the limited membrane permeability of
the cleaved dye.23
We next investigated the intracellular gating of the nanozyme by CB[7]
complexation. Flow cytometry showed that the NR_Ru_CB[7] particles were completely
inhibited, indicating intracellular stability of the complexes (Figure 6.13a). Treatment
with ADA (400 mM) restored nanozyme activity, with even higher activity observed in
the cells after treatment with ADA than was observed with NR_Ru (Figure 6.13b). This
increased catalytic efficiency is echoed in the micrograph (Figure 5.13f) and potentially
arises from enhanced protection of the catalyst by the CB[7] coverage.
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Figure 6.13 Triggered allylcarbamate cleavage in living cells using gated nanozymes. (a)
Flow cytometry of NP_Ru and controls (b) Recovery of catalysis through addition of
ADA to NP_Ru_CB[7] treated cells. (c-f) Confocal microscopy images of HeLa cells
showing the supramolecularly regulated intracellular chemical reactions (scale bars = 10
µm)
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Figure 6.14 The confocal images of the cell treated with the nanozymes, substrates, and
lysotracker (a); the nanozyme-bound-CB[7], substrate, ADA, and lysotracker (b).

6.3 Summary and future outlook
In conclusion, we have described the fabrication of a AuNP based, bioorthogonal
nanozyme. These catalysts were built upon a platform featuring biomimetic size and
surface functionality. Host-guest interactions of CB[7] molecules with the benzyl
headgroup of the AuNP ligands on these particles provided allosteric control of the
nanozyme activity, providing an efficient and reversible means of regulating catalysis.
Future studies will explore the use of this artificial enzyme to control the
bioprocesse or treatment of many enzyme-involved diseases. The adjusted steric
hindrance from the complexation of host-guest can be used for selective reactions,
targeting the certain sized substrates. Taken together, this system integrates biomimetic
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and bioorthogonal design elements to provide a new tool for potential applications in
imaging and therapeutics.

6.4 Synthesis of materials and experimental methods
6.4.1 Synthesis of ligand and fabrication of nanoparticle

6.4.1.1 Synthesis of the benzyl ligand

Figure 6.15 Synthetic scheme of the benzyl ligand for the functionalization of the
nanoparticle.
6.4.1.2 General procedure:
Compound 2: 11-bromo-1-undecanol (1, 8.22 g, 32.74 mmol) was dissolved in 1:1
ethanol/toluene mixture (150 ml). Triphenylmethanethiol (10.86 g, 39.29 mmol)
dissolved in 1:1 ethanol/toluene (50 ml) was added to 11-bromo-1-undecanol in solution.
Then NaOH (1.96 g, 49.11 mmol) dissolved in 3 ml water was slowly added to the
mixture. The reaction mixture was stirred for 24 h at 50°C. Upon completion, the reaction
mixture was extracted with a saturated solution of NaHCO3 twice. The organic layer was
extracted, dried over Na2SO4, and concentrated by evaporation of the solvent. The crude
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product was purified by column chromatography over silica gel using hexane/ethyl
acetate (1:1, v/v) as the eluent. The solvent was removed in vacuum to obtain compound
2 as colorless oil (Yield 13.88 g, 95%).

Figure 6.16 1H NMR spectrum (400 MHz) of compound 2 in CDCl3 (D, 99.8%).

Compound 3: Compound 2 (13.88 g, 31.1 mmol) in dry dichloromethane (DCM, 200
ml) was mixed with triethylamine (4.72g, 6.48 mL, 46.65 mmol), followed by dropwise
addition of methanesulfonyl chloride (3.92 g, 2.65mL, 34.21 mmol) in ice bath. After 30
min the reaction mixture was warmed up to room temperature and stirred overnight. After
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the reaction was completed (according to thin layer chromatography; TLC), solvent was
evaporated. The compound was again diluted with DCM and extracted with 0.1 M HCl
twice. The organic layer was collected, treated with a saturated solution of NaHCO3, and
washed three times. Following extraction, the organic layer was dried over Na2SO4 and
concentrated at reduced pressure. The crude product was purified by column
chromatography over silica gel using hexane/ethyl acetate (1:1, v/v) as the eluent. Solvent
was removed in vacuum to obtain mesylated compound as light yellow oil (Yield 15 g,
92%). To synthesize compound 3, NaOH (1.37 g, 34.3 mmol) solution (1 mL) was added
to 99.24 mL of tetraethyleneglycol (111.15 g, 57.22 mmol) and stirred for 2 h at 80°C. To
this reaction mixture, 15 g of 11-(tritylthio)undecyl methanesulfonate was added and
stirred for 24 h at 100°C. The product was extracted in hexane/ethyl acetate (4:1, v/v) six
times. Then, the organic layer was concentrated at reduced pressure and the crude
product was purified by column chromatography over silica gel using ethyl acetate as the
eluent. The solvent was removed in vacuum to obtain compound 3 as light yellow oil
(Yield 15.28 g, 68%).
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Figure 6.17 1H NMR spectrum (400 MHz) of compound 3 in CDCl3 (D, 99.8%).

Compound 4: Triethylamine (3.26g, 4.49 mL, 32.2 mmol) was added to compound 3 (10
g, 16.1 mmol) in dry DCM (80 ml) in an ice bath. Methanesulfonyl chloride (2.77 g, 1.87
mL, 24.1 mmol) was added dropwise to the reaction mixture in an ice bath. After 30 min
the reaction mixture was warmed up to room temperature and stirred overnight. The
reaction mixture was worked up and the organic layer was extracted. The extracted DCM
layer was dried over Na2SO4 and concentrated at reduced pressure. The crude product
was purified by column chromatography over silica gel using ethyl acetate as the eluent.
Solvent was removed in vacuum to obtain compound 4 as light yellow oil (Yield 10.7 g,
95 %).
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Figure 6.18 1H NMR spectrum (400 MHz) of compound 4 in CDCl3 (D, 99.8%).

Compound 5: Compound 4 (1.075 g, 1.53 mmol) was added to dimethylbenzylamine
(0.62 g, 0.7 ml, 4.6 mmol) in ethanol (8 ml). The reaction mixture was stirred at 40°C for
48 h. After evaporating ethanol at reduced pressure, the light yellow residue was purified
by successive washings with hexane (four times) and hexane/diethylether (1:1 v/v, six
times) and then dried under high vacuum. The product formation was around 100% and
the product was confirmed by NMR.
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Figure 6.19 1H NMR spectrum (400 MHz) of compound 5 in CDCl3 (D, 99.8%).

Compound 6: An excess of trifluoroacetic acid (TFA, 20 equivalents, 3.69 g, 2.5 mL,
32.4 mmol) was added to compound 5 (1.2 g, 1.62 mmol) in dry DCM (5 ml). The color
of the solution was turned to yellow upon addition of TFA. Then, triisopropylsilane
(TIPS, three equivalents, 0.77g, 1 mL, 4.86 mmol) was added to the reaction mixture.
The reaction mixture was stirred 5 hr under N2 at room temperature. The solvent, most of
TFA, and TIPS were evaporated under reduced pressure. The yellow residue was purified
by hexane washings (four times) and dried under high vacuum. The final product
formation was around 100% and the structure of compound 6 was confirmed by NMR.
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Figure 6.20 1H NMR spectrum (400 MHz) of benzyl ligand in CDCl3 (D, 99.8%).

6.4.1.3 Synthesis of benzyl-ligand-protected gold nanoparticle (AuNP)
First, Brust-Schiffrin two-phase synthesis method was used to synthesize pentanethiolcoated AuNPs with core diameter ca. 2 nm.24 Murray place-exchange method25 was
followed to obtain the benzyl-ligand-protected AuNPs. Pentanethiol-conjugated AuNPs
(10 mg) and thiol ligand (compound 5) (30 mg) were dissolved in a mixture of dry DCM
(3 ml) and methanol (1 ml) and stirred under N2 atmosphere for 3 days at room
temperature. The DCM was removed under reduced pressure and the resulting precipitate
was washed with hexane three times and DCM twice. Then the precipitate was dissolved
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in distilled water and dialyzed for three days (membrane molecular weight cut-off
=10,000) to remove excess ligands, pentanethiol, acetic acid, and other salts present in
the nanoparticle solution. After dialysis, the particle was lyophilized to yield a solid
brownish product. The particles were then redispersed in deionized water. 1H NMRspectra in D2O showed substantial broadening of the proton peaks with no sign of free
ligands. The presence of ligands was also confirmed by mass spectroscopy.

Figure 6.21 1H NMR spectrum (400 MHz) of benzyl-AuNPs in D2O (D, 99.8%).
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6.4.1.4 Mass spectrometric characterization of ligand composition
Matrix assisted laser desorption/ionization mass spectroscopy (MALDI-MS) has been
performed to characterize the surface ligand on the Benzyl-AuNP. 26 A saturated αCyano-4-hydroxycinnamic acid (α-CHCA) stock solution was prepared in 70%
acetonitrile, 30% H2O, and 0.1% trifluoroacetic acid. An equal volume of 2 µM NP
solution was added to the matrix stock solution. 2.5 µL of this mixture was applied to the
sample carrier, and then the MALDI-MS analysis was performed on a Bruker Autoflex
III mass spectrometer. The molecular ions (MH+, m/z =498) were detected, and the
disulfide ion formed by the benzyl ligand and the original pentanethiol was also detected
at m/z 600.
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Figure 6.22 MALDI-MS spectrum of benzyl-AuNP.

6.4.2 Experimental methods
6.4.2.1 Catalyst encapsulation into the monolayer of AuNPs
The catalyst, [Cp*Ru(cod)Cl], and the AuNP were dissolved in an acetone/water mixture
and then the acetone was slowly removed by evaporation. During the evaporation the
catalyst was encapsulated in the particle monolayer, with excess catalyst precipitating and
removed by filtration. The AuNPs were purified by multiple filtrations and dialyzed
against water to remove free catalysts. The amount of encapsulated catalyst was
measured by ICP-MS by tracking 101Ru relative to 197Au.
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6.4.2.2 Kinetic studies of nanozymes using Lineweaver–Burk analysis
In the titration of the reaction rate of the nanozyme using the CB[7], 400 nM of the
AuNPs, 20 µM of the substrate, and set molar ratios of CB[7]s were used in DI water. For
the Lineweaver-Burk analysis, 400 nM of the AuNPs, 2, 4, 20, 40, and 80 µM of the
substrate, and 0, 4, 16, and 80 µM of CB[7] were used. The concentration of the products
was calculated based on the fluorescence standard curve of Rhodamine 110 (Figure 5.23).

Figure 6.23 The standard curve of the Rhodamine 110 for the calculation of the reaction
rate.

183

	
  

6.4.2.3 Catalytic activity of the nanozymes inside living cells
HeLa cells were grown in a cell culture flask using low-glucose Dulbecco’s modified
Eagle medium supplemented with 10% fetal bovine serum at 37°C in a humidified
atmosphere of 5% CO2. For confocal and flow cytometry analysis, HeLa cells were
seeded at 20,000 and 80,000 cells in 0.5 mL per well in 24-well plates 24 h prior to the
experiment. During the experiment old media were replaced by 200 nM of the
nanozymes and the nanozyme-bound CB[7] in serum-containing media and the cells
were incubated for 24 h and washed with PBS buffer three times. 100 µM of the
substrates were then added to the cells and incubated for 24 h. The cells were then
washed with PBS three times. For the cytometry, a Becton Dickinson LSR cytometer was
used. A total of 10,000 events per sample were analyzed. A530/30 bandpass filter (FITC)
was used for rhodamine 110. Confocal microscopy images were obtained on a Zeiss LSM
510 Meta microscope by using a 63× objective. The settings of the confocal microscope
were as follows unless otherwise specified: green channel: λex=488 nm and λem=BP 505530 nm; red channel: λex=543 nm and λem=LP 650 nm. Emission filters: BP=band pass,
LP=high pass. LysoTracker® Red DND-99 was obtained from Invitrogen. 100 nM of
LysoTracker® was incubated with cells for 30 min prior to the microscopy experiments.
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